{"content":"<li class=\"n-box-item date-title\" data-end=\"1541480399\" data-start=\"1541394000\" data-txt=\"Monday, December 23, 2019\">Monday, November  5, 2018</li><li class=\"n-box-item sa-box-item\" data-id=\"3405546\" data-ts=\"1541463564\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NTR\" target=\"_blank\">NTR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3405546-nutrienplus-3-after-q3-earnings-top-estimates-potash-production-rises-17\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nutrien +3% after Q3 earnings top estimates, potash production rises 17%</a></h4><ul>\n<li>Nutrien (NYSE:<a href='https://seekingalpha.com/symbol/NTR' title='Nutrien Ltd.'>NTR</a>) <font color=\"green\">+3.3%</font> after-hours as it reports better than expected <a href=\"https://seekingalpha.com/news/3405536-nutrien-beats-0_03-beats-revenue\" target=\"_blank\">Q3 earnings</a>, <a href=\"https://seekingalpha.com/news/3405534-nutrien-declares-0_43-dividend\" target=\"_blank\">raises its dividend</a> and lifts its full-year adjusted profit forecast, driven by <a href=\"https://www.reuters.com/article/nutrien-results/update-1-fertilizer-maker-nutriens-profit-beats-on-strong-potash-demand-idUSL4N1XG6TW\" target=\"_blank\">strong demand for its potash fertilizers</a>.</li>\n<li>NTR says Q3 adjusted earnings exclude a non-cash impairment of $1.8B after deciding to permanently close its New Brunswick potash facility following a strategic review of its potash portfolio.</li>\n<li>The company says it remains positive on the long-term fundamentals for potash and the opportunity to ramp up production from its low-cost Saskatchewan mines to meet growth in global demand.</li>\n<li>NTR issues in-line guidance for Q4 adjusted EPS of $0.46-$0.66 vs. $0.61 analyst consensus estimate, raises guidance for FY 2018 adjusted EPS to $2.60-$2.80 from $2.40-$2.70 previously vs. $2.69 consensus, and raises guidance for full-year adjusted EBITDA to $3.85B-$4.05B from $3.7B-$4B previously.</li>\n<li>For Q3, NTR says potash sales volumes rose 17% Y/Y to 3.9M metric tons at an average realized price of $212/ton; for the full year, NTR raises its guidance range for potash volumes to 12.5M-13M metric tons.</li>\n<li>NTR says it now expects to achieve its $500M annual run-rate synergy target by the end of 2018 and raises guidance on the annual run-rate synergy target to $600M by the end of 2019.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3405546\" data-linked=\"Nutrien +3% after Q3 earnings top estimates, potash production rises 17%\" data-tweet=\"$NTR - Nutrien +3% after Q3 earnings top estimates, potash production rises 17% https://seekingalpha.com/news/3405546-nutrienplus-3-after-q3-earnings-top-estimates-potash-production-rises-17?source=tweet\" data-url=\"https://seekingalpha.com/news/3405546-nutrienplus-3-after-q3-earnings-top-estimates-potash-production-rises-17\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:19 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3405544\" data-ts=\"1541461410\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MTW\" target=\"_blank\">MTW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3405544-manitowocplus-8-after-easily-beating-q3-earnings-estimates\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Manitowoc +8% after easily beating Q3 earnings estimates</a></h4><ul>\n<li>Manitowoc (NYSE:<a href='https://seekingalpha.com/symbol/MTW' title='Manitowoc Company, Inc.'>MTW</a>) <font color=\"green\">+8%</font> after-hours as it easily tops <a href=\"https://seekingalpha.com/news/3405360-manitowoc-beats-0_12-misses-revenue\" target=\"_blank\">Q3 earnings</a> expectations with a 13% Y/Y revenue increase to $450M attributable to improved crane shipments across all regions.</li>\n<li>MTW says Q3 adjusted EBITDA rose 34% Y/Y to $30.5M from $22.7M in the year-ago quarter; Q3 orders of $458M were 22% higher than the year-ago period, and backlog of $700M at Sept. 30 was 50% higher than the prior-year quarter.</li>\n<li>MTW issues downside revenue guidance for FY 2018, expecting $1.8B-$1.825B vs. $1.85B analyst consensus; it also forecasts full-year adjusted EBITDA of $105M-$115M.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3405544\" data-linked=\"Manitowoc +8% after easily beating Q3 earnings estimates\" data-tweet=\"$MTW - Manitowoc +8% after easily beating Q3 earnings estimates https://seekingalpha.com/news/3405544-manitowocplus-8-after-easily-beating-q3-earnings-estimates?source=tweet\" data-url=\"https://seekingalpha.com/news/3405544-manitowocplus-8-after-easily-beating-q3-earnings-estimates\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:43 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3405543\" data-ts=\"1541460362\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CRZO\" target=\"_blank\">CRZO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3405543-carrizo-oilplus-2-after-easy-q3-earnings-beat-raised-production-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Carrizo Oil +2% after easy Q3 earnings beat, raised production guidance</a></h4><ul>\n<li>Carrizo Oil &amp; Gas (NASDAQ:<a href='https://seekingalpha.com/symbol/CRZO' title='Carrizo Oil & Gas, Inc.'>CRZO</a>) <font color=\"green\">+2.3%</font> after-hours as it easily beats expectations for both <a href=\"https://seekingalpha.com/news/3405348-carrizo-oil-and-gas-beats-0_15-beats-revenue\" target=\"_blank\">Q3 earnings</a> and revenues, and raises its full-year production guidance.</li>\n<li>CRZO says Q3 production rose 17% Y/Y to 64,627 boe/day, above the high end of its guidance range, including crude oil production of 40,813 bbl/day, up 17% Y/Y and 8% Q/Q; the company raises FY 2018 production guidance to 60.2K-60.5K boe/day from its previous outlook of 58.7K-60.1K boe/day.</li>\n<li>For Q4, CRZO expects production of 67.7K-68.7K boe/day (63% oil), with results held down by delays caused by heavy rains in Texas as well as maintenance on the DCP natural gas gathering system.</li>\n<li>For FY 2018, CRZO maintains drilling, completion and infrastructure capex guidance of $800M-$825M, with completion activity expected to decline in Q4 as the company\u2019s 2018 development plan includes a frac holiday during the quarter.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3405543\" data-linked=\"Carrizo Oil +2% after easy Q3 earnings beat, raised production guidance\" data-tweet=\"$CRZO - Carrizo Oil +2% after easy Q3 earnings beat, raised production guidance https://seekingalpha.com/news/3405543-carrizo-oilplus-2-after-easy-q3-earnings-beat-raised-production-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3405543-carrizo-oilplus-2-after-easy-q3-earnings-beat-raised-production-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:26 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3405536\" data-ts=\"1541458990\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NTR\" target=\"_blank\">NTR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3405536-nutrien-beats-0_03-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nutrien beats by $0.03, beats on revenue</a></h4><ul>\n<li>Nutrien (NYSE:<a href='https://seekingalpha.com/symbol/NTR' title='Nutrien Ltd.'>NTR</a>): Q3 Non-GAAP EPS of $0.47 <span style=\"color:green\">beats by $0.03</span>.</li>\n<li>Revenue of $4.03B (+12.3% Y/Y) <font color=\"green\">beats by $200M</font>.</li>\n<li>Shares <font color=\"green\">+1.5%</font> AH.</li>\n<li><a href=\"https://seekingalpha.com/pr/17323239-nutrien-reports-solid-3rd-quarter-operating-results-raises-2018-guidance-dividend-synergy\">Press Release</a></li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3405536\" data-linked=\"Nutrien beats by $0.03, beats on revenue\" data-tweet=\"$NTR - Nutrien beats by $0.03, beats on revenue https://seekingalpha.com/news/3405536-nutrien-beats-0_03-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3405536-nutrien-beats-0_03-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:03 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3405535\" data-ts=\"1541458744\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LTHM\" target=\"_blank\">LTHM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3405535-fmc-little-changed-after-q3-earnings-livent-spinoffminus-4-after-report\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FMC little changed after Q3 earnings; Livent spinoff -4% after its report</a></h4><ul>\n<li>Livent Corp. (NYSE:<a href='https://seekingalpha.com/symbol/LTHM' title='Livent'>LTHM</a>), the lithium producer spun off last month from FMC Corp., <font color=\"red\">-3.8%</font> after-hours as it posted in-line <a href=\"https://seekingalpha.com/news/3405476-livent-beats-0_02-misses-revenue\" target=\"_blank\">Q3 earnings</a> and <a href=\"https://www.reuters.com/article/us-livent-results/livent-profit-fails-to-beat-expectations-shares-drop-idUSKCN1NA2OB\" target=\"_blank\">narrowed its full-year sales forecast</a>.</li>\n<li>Livent says it now expects FY 2018 sales of $440M-$450M, after CEO Paul Graves said last month that he stood by FMC\u2019s prior forecast for 2018 lithium sales of $430M-$460M.</li>\n<li>Meanwhile, <a href='https://seekingalpha.com/symbol/FMC' title='FMC Corporation'>FMC</a> is little changed after-hours as it reports better than expected <a href=\"https://seekingalpha.com/news/3405437-fmc-beats-0_06-beats-revenue\" target=\"_blank\">Q3 earnings</a> but issues downside guidance for Q4 EPS of $1.40-$1.50 vs. $1.51 analyst consensus estimate.</li>\n<li>FMC, which owns ~86% of Livent\u2019s shares, says it plans to report lithium division results as part of its own results through Q4 and that it plans to sell its stake in Livent by next March.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3405535\" data-linked=\"FMC little changed after Q3 earnings; Livent spinoff -4% after its report\" data-tweet=\"$LTHM $LTHM $FMC - FMC little changed after Q3 earnings; Livent spinoff -4% after its report https://seekingalpha.com/news/3405535-fmc-little-changed-after-q3-earnings-livent-spinoffminus-4-after-report?source=tweet\" data-url=\"https://seekingalpha.com/news/3405535-fmc-little-changed-after-q3-earnings-livent-spinoffminus-4-after-report\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:59 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3405530\" data-ts=\"1541457792\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MOS\" target=\"_blank\">MOS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3405530-mosaicplus-6-after-strong-q3-earnings-beat-raised-full-year-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Mosaic +6% after strong Q3 earnings beat, raised full-year guidance</a></h4><ul>\n<li>Mosaic (NYSE:<a href='https://seekingalpha.com/symbol/MOS' title='The Mosaic Company'>MOS</a>) <font color=\"green\">+6.1%</font> after-hours as it easily beats <a href=\"https://seekingalpha.com/news/3405422-mosaic-beats-0_09-beats-revenue\" target=\"_blank\">Q3 earnings</a> expectations and revenues surge 48% Y/Y to $2.93B, as it raises guidance for full-year earnings and adjusted EBITDA.</li>\n<li>MOS issues upside guidance for FY 2018, seeing EPS of $1.80-$2.00 from its earlier outlook for $1.45-$1.80 and above $1.77 analyst consensus estimate, and raises guidance for full-year adjusted EBITDA to $1.9B-$2B from  $1.8B-$1.95B previously, citing strong underlying business performance.</li>\n<li>MOS says Q3 sales in its phosphates segment rose 28% Y/Y to $1B from $779M in the year-ago quarter, driven by higher average sales prices and higher sales volumes, with gross margin of $180M vs. $67M a year ago.</li>\n<li>Q3 potash sales also increased 28% Y/Y to $609M from $474M a year ago, driven by both higher average sales prices and higher sales volumes, with gross margin of $161M vs. $99M for the same period last year.</li>\n<li>Q3 sales in Mosaic Fertilizantes jumped 74% to $1.4B from $806M last year, primarily driven by the acquisition of Vale Fertilizantes and higher margins in the legacy distribution business; gross margin in the segment nearly tripled to $152M.</li>\n<li>MOS also says it completed its commitment to repay $700M of long-term debt, two years ahead of the initial 2020 target.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3405530\" data-linked=\"Mosaic +6% after strong Q3 earnings beat, raised full-year guidance\" data-tweet=\"$MOS - Mosaic +6% after strong Q3 earnings beat, raised full-year guidance https://seekingalpha.com/news/3405530-mosaicplus-6-after-strong-q3-earnings-beat-raised-full-year-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3405530-mosaicplus-6-after-strong-q3-earnings-beat-raised-full-year-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:43 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3405529\" data-ts=\"1541457603\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ELF\" target=\"_blank\">ELF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3405529-after-hours-elf-leads-gainers-losers-include-nbix-and-thc\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After hours: ELF leads gainers, losers include NBIX and THC</a></h4><ul> <li>\n<b>Top Gainers:</b> <a href='https://seekingalpha.com/symbol/ELF' title='e.l.f. Beauty'>ELF</a> <font color=\"green\">+18.5%</font>. <a href='https://seekingalpha.com/symbol/CVGI' title='Commercial Vehicle Group, Inc.'>CVGI</a> <font color=\"green\">+12.8%</font>. <a href='https://seekingalpha.com/symbol/FN' title='Fabrinet'>FN</a> <font color=\"green\">+11.3%</font>. <a href='https://seekingalpha.com/symbol/ATUS' title='Altice USA'>ATUS</a> <font color=\"green\">+8.8%</font>. <a href='https://seekingalpha.com/symbol/LASR' title='nLIGHT, Inc.'>LASR</a> <font color=\"green\">+5.7%</font>.</li> <li>\n<b>Top </b><b>Losers: </b><a href='https://seekingalpha.com/symbol/FTDR' title='frontdoor, inc.'>FTDR</a> <font color=\"red\">-8.9%. </font><a href='https://seekingalpha.com/symbol/NEOS' title='Neos Therapeutics'>NEOS</a> <font color=\"red\">-7.8%</font> <a href='https://seekingalpha.com/symbol/NBIX' title='Neurocrine Biosciences, Inc.'>NBIX</a> <font color=\"red\">-6.2%</font>. <a href='https://seekingalpha.com/symbol/IIN' title='IntriCon Corporation'>IIN</a> <font color=\"red\">-6.2%</font>. <a href='https://seekingalpha.com/symbol/THC' title='Tenet Healthcare Corporation'>THC</a> <font color=\"red\">-5.2%.</font>\n</li> </ul><div class=\"tiny-share-widget\" data-id=\"3405529\" data-linked=\"After hours: ELF leads gainers, losers include NBIX and THC\" data-tweet=\"$ELF $ELF $CVGI - After hours: ELF leads gainers, losers include NBIX and THC https://seekingalpha.com/news/3405529-after-hours-elf-leads-gainers-losers-include-nbix-and-thc?source=tweet\" data-url=\"https://seekingalpha.com/news/3405529-after-hours-elf-leads-gainers-losers-include-nbix-and-thc\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:40 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3405511\" data-ts=\"1541456260\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EYPT\" target=\"_blank\">EYPT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3405511-eyepointplus-4-on-china-license-deal-for-durasert-treatment\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">EyePoint +4% on China license deal for Durasert treatment</a></h4><ul>\n<li>EyePoint Pharma (NASDAQ:<a href='https://seekingalpha.com/symbol/EYPT' title='EyePoint Pharmaceuticals, Inc.'>EYPT</a>) has inked a deal with Ocumension Therapeutics for the development and commercialization of EyePoint's three-year micro insert using the Durasert technology for chronic, non-infectious posterior segment uveitis in the greater China territory.</li>\n<li>EyePoint will receive an upfront payment of $1.75M and up to $10M over time should certain development, regulatory, and sales milestones be hit.</li>\n<li>Shares <font color=\"green\">+3.9%</font> after hours</li>\n<li>Source: <a href=\"https://seekingalpha.com/pr/17323037-eyepoint-pharmaceuticals-ocumension-therapeutics-sign-exclusive-license-agreement-develop\" target=\"_blank\">Press Release</a>\n</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3405511\" data-linked=\"EyePoint +4% on China license deal for Durasert treatment\" data-tweet=\"$EYPT - EyePoint +4% on China license deal for Durasert treatment https://seekingalpha.com/news/3405511-eyepointplus-4-on-china-license-deal-for-durasert-treatment?source=tweet\" data-url=\"https://seekingalpha.com/news/3405511-eyepointplus-4-on-china-license-deal-for-durasert-treatment\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:17 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3405509\" data-ts=\"1541456157\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JBGS\" target=\"_blank\">JBGS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3405509-jbg-smith-jumps-4_3-after-dc-suburb-seen-frontrunner-for-amazon-hq2\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">JBG Smith jumps 4.3% after DC suburb seen as frontrunner for Amazon HQ2</a></h4><ul>\n<li>JBG Smith (NYSE:<a href='https://seekingalpha.com/symbol/JBGS' title='JBG SMITH Properties'>JBGS</a>) closes<font color=\"green\"> up 4.3%</font> Monday after reports name northern Virginia's Crystal City--a Washington,DC, suburb--as a <a href=\"https://www.wsj.com/articles/amazon-plans-to-split-hq2-evenly-between-two-cities-1541446552?mod=hp_lead_pos1\" target=\"_blank\">front-runner</a> for one of the two final locations for Amazon's (NASDAQ:<a href='https://seekingalpha.com/symbol/AMZN' title='Amazon.com, Inc.'>AMZN</a>) H2Q.</li>\n<li>JBG Smith is a big owner of office space in the DC area.</li>\n<li>Other REITs with DC properties include Washington Real Estate Investment Trust (NYSE:<a href='https://seekingalpha.com/symbol/WRE' title='Washington Real Estate Investment'>WRE</a>), <font color=\"green\">up 2.3%</font>, and Government Properties Income Trust (NYSE:<a href='https://seekingalpha.com/symbol/GOV-OLD' title='Government Properties Income Trust'>GOV-OLD</a>),  <font color=\"green\">up 2.2%</font>.</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3405296-wsj-amazon-will-split-hq2-two-cities\" target=\"_blank\">WSJ: Amazon will split HQ2 between two cities</a> (Nov. 5)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3405509\" data-linked=\"JBG Smith jumps 4.3% after DC suburb seen as frontrunner for Amazon HQ2\" data-tweet=\"$JBGS $JBGS $AMZN - JBG Smith jumps 4.3% after DC suburb seen as frontrunner for Amazon HQ2 https://seekingalpha.com/news/3405509-jbg-smith-jumps-4_3-after-dc-suburb-seen-frontrunner-for-amazon-hq2?source=tweet\" data-url=\"https://seekingalpha.com/news/3405509-jbg-smith-jumps-4_3-after-dc-suburb-seen-frontrunner-for-amazon-hq2\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:15 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3405508\" data-ts=\"1541456021\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ATUS\" target=\"_blank\">ATUS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3405508-altice-usaplus-4_8-after-best-financials-yet\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Altice USA +4.8% after best financials yet</a></h4><ul>   <li>Altice USA (NYSE:<a href='https://seekingalpha.com/symbol/ATUS' title='Altice USA'>ATUS</a>) has <font color=\"green\">gained 4.8%</font> postmarket following its Q3 earnings beat, featuring its best financial performance yet and spurring the company to target $500M in buybacks in the second half.</li>    <li>EBITDA rose 5.8% to $1.07B. And the company swung to a gain of $32.5M, vs. a year-ago loss of $192.6M.</li>    <li>Unique residential customer relationships were flat, with quarterly declines of just 5,000 vs. a drop of 8,000 a year ago. Pay TV RGU net losses were 28,000 (vs. loss of 33,000 a year ago); residential broadband RGU had quarterly adds of 14,000 (vs. 16,000 last year), and residential ARPU rose 2.3% to $143.</li>    <li>Revenue breakout: Pay TV, $1.05B (down 1.4%); Broadband, $729.9M (up 10.9%); Telephony, $161.35M (down 6.5%); Business services and wholesale, $344.2M (up 6%); Advertising, $123.1M (up 37.8%).</li>    <li>Operating free cash flow was $736M (down 2.8%); free cash flow rose 28% to $276M.</li>    <li>For the full year, it's expecting revenue growth of 2.5-3%, EBITDA margin expansion and capex under $1.3B despite plans to increase investment in Altice One, fiber deployment and a new mobile network.</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3405445-altice-usa-beats-0_03-beats-revenue\" target=\"_blank\">Altice USA beats by $0.03, beats on revenue</a> (Nov. 05 2018)</li>    <li><a href=\"https://seekingalpha.com/pr/17322980-altice-usa-reports-third-quarter-2018-results\" target=\"_blank\">Press release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3405508\" data-linked=\"Altice USA +4.8% after best financials yet\" data-tweet=\"$ATUS - Altice USA +4.8% after best financials yet https://seekingalpha.com/news/3405508-altice-usaplus-4_8-after-best-financials-yet?source=tweet\" data-url=\"https://seekingalpha.com/news/3405508-altice-usaplus-4_8-after-best-financials-yet\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:13 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3405506\" data-ts=\"1541455963\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NEOS\" target=\"_blank\">NEOS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3405506-neos-thera-down-11_6-on-capital-raise\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Neos Thera down 11.6% on capital raise</a></h4><ul>\n<li>The company is offering an undisclosed amount of shares, with underwriter greenshoe for another 15% of the number of shares sold.</li>\n<li>The deal is being underwritten by Cantor Fitzgerald.</li>\n<li><a href='https://seekingalpha.com/symbol/NEOS' title='Neos Therapeutics'>NEOS</a> <font color=\"red\">-11.6%</font> after hours</li>\n<li>Source: <a href=\"https://seekingalpha.com/pr/17322959-b-neos-b-therapeutics-announces-proposed-offering-common-stock\" target=\"_blank\">Press Release</a>\n</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3405506\" data-linked=\"Neos Thera down 11.6% on capital raise\" data-tweet=\"$NEOS - Neos Thera down 11.6% on capital raise https://seekingalpha.com/news/3405506-neos-thera-down-11_6-on-capital-raise?source=tweet\" data-url=\"https://seekingalpha.com/news/3405506-neos-thera-down-11_6-on-capital-raise\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:12 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3405496\" data-ts=\"1541455775\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AVEO\" target=\"_blank\">AVEO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3405496-aveo-oncology-up-17-on-positive-test-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AVEO Oncology up 17% on positive test results</a></h4><ul>\n<li>The company's TIVO-3 trial to compare tivozanib (FOTIVDA®) to sorafenib met its primary endpoint of demonstrating a statistically significant benefit in progression-free survival &#40;PFS&#41;.</li>\n<li>Tivozanib demonstrated a 44% improvement in median PFS and 26% reduction in risk of progression or death (Hazard Ratio [HR]=0.74, p=0.02).</li>\n<li>A <a href=\"http://www.aveooncology.com\" target=\"_blank\">conference call</a> is just underway.</li>\n<li>Source: <a href=\"https://seekingalpha.com/pr/17323002-b-aveo-b-oncology-announces-phase-3-tivominus-3-trial-tivozanib-renal-cell-carcinoma-meets\" target=\"_blank\">Press Release</a>\n</li>\n<li><a href='https://seekingalpha.com/symbol/AVEO' title='AVEO Pharmaceuticals, Inc.'>AVEO</a> <font color=\"green\">+17.7%</font> after hours</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3405496\" data-linked=\"AVEO Oncology up 17% on positive test results\" data-tweet=\"$AVEO - AVEO Oncology up 17% on positive test results https://seekingalpha.com/news/3405496-aveo-oncology-up-17-on-positive-test-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3405496-aveo-oncology-up-17-on-positive-test-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:09 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>45&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3405485\" data-ts=\"1541455405\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/APPS\" target=\"_blank\">APPS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3405485-digital-turbineplus-7_1-after-q2-revenue-margin-growth\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Digital Turbine +7.1% after Q2 revenue, margin growth</a></h4><ul>   <li>Digital Turbine (NASDAQ:<a href='https://seekingalpha.com/symbol/APPS' title='Digital Turbine, Inc.'>APPS</a>) has <font color=\"green\">jumped 7.1%</font> after hours after its <a href=\"https://seekingalpha.com/news/3405388-digital-turbine-reports-q2-results\" target=\"_blank\">Q2 results</a> showed near-50% growth in revenues and improved gross margins.</li>    <li>The company swung to a non-GAAP profit of $1.1M vs. a loss of $1M a year ago.</li>    <li>EBITDA was $1.6M, vs. a year-ago $0.1M EBITDA loss.</li>    <li>Digital Turbine divested its Content and Advertisers &amp; Publishers businesses in two separate transactions this summer, and has reflected them as discontinued operations.</li>    <li>Ignite installations have hit 200M total devices, with almost 25M installs in the September quarter.</li>    <li>Free cash flow was $1.6M, up from a year-ago $1.2M .</li>    <li>For Q3 it's guiding to revenues of $28M-$30M (vs. consensus for $28.5M) and EBITDA of $1.8M-$2.2M.</li>    <li><a href=\"https://seekingalpha.com/pr/17323077-digital-turbine-reports-fiscal-2019-second-quarter-results\" target=\"_blank\">Press release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3405485\" data-linked=\"Digital Turbine +7.1% after Q2 revenue, margin growth\" data-tweet=\"$APPS - Digital Turbine +7.1% after Q2 revenue, margin growth https://seekingalpha.com/news/3405485-digital-turbineplus-7_1-after-q2-revenue-margin-growth?source=tweet\" data-url=\"https://seekingalpha.com/news/3405485-digital-turbineplus-7_1-after-q2-revenue-margin-growth\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:03 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3405483\" data-ts=\"1541455384\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INSY\" target=\"_blank\">INSY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3405483-insys-q3-top-line-down-40-shares-down-5-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">INSYS Q3 top line down 40%; shares down 5% after hours</a></h4><ul>\n<li>INSYS Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/INSY' title='Insys Therapeutics, Inc.'>INSY</a>) <a href=\"https://seekingalpha.com/pr/17323087-insys-therapeutics-reports-third-quarter-2018-results\" target=\"_blank\">Q3 results</a> ($M): Revenue: 18.3 (-40.4%). Revenue drop due mainly to continued weakness in transmucosal immediate-release fentanyl &#40;TIRF&#41; market (Subsys).</li>\n<li>Net loss: (30.6) (+81.6%); loss/share: (0.41) (+82.0%).</li>\n<li>Shares are down <font color=\"red\">5%</font> after hours.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3405483\" data-linked=\"INSYS Q3 top line down 40%; shares down 5% after hours\" data-tweet=\"$INSY $INSYQ - INSYS Q3 top line down 40%; shares down 5% after hours https://seekingalpha.com/news/3405483-insys-q3-top-line-down-40-shares-down-5-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3405483-insys-q3-top-line-down-40-shares-down-5-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:03 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3405479\" data-ts=\"1541455302\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SBRA\" target=\"_blank\">SBRA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3405479-sabra-health-care-reit-sinks-3_2-after-cutting-guidance-on-lease-termination\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sabra Health Care REIT sinks 3.2% after cutting guidance on lease termination</a></h4><ul> <li>Sabra Health Care REIT (NASDAQ:<a href='https://seekingalpha.com/symbol/SBRA' title='Sabra Health Care REIT, Inc.'>SBRA</a>) <font color=\"red\">slumps 3.2%</font> in after-hours trading after 2018 <a href=\"https://seekingalpha.com/pr/17323141-sabra-reports-third-quarter-2018-results-continued-improvement-skilled-nursing-occupancy\" target=\"_blank\">normalized FFO per share</a> guidance is cut to $2.27-$2.30 from prior view of $2.47-$2.55.</li> <li>The forecast cut results from SBRA issuing Senior Care Centers notices of default and lease termination due to non-payment of rent under the terms of master leases. Senior Care Centers are now operating facilities on a month-by-month basis.</li> <li>\"There can be no assurances that we will receive any additional rent payments from Senior Care Centers during the pendency of the sale process,\" SBRA says in its earnings release.</li> <li>In August, SBRA entered a non-binding LOI to sell the 36 skilled nursing facilities and two senior housing communities currently leased to Senior Care Centers for an aggregate sales price of $405.0M.</li> <li>SBRA expects to complete the sale in early 2019. There's no assurances that a definitive agreement will be reached, though.</li> <li>Q3 normalized FFO of 60 cents missed consensus by 2 cents and compares with 63 cents in the year-ago period.</li> <li>\n<a href=\"https://edge.media-server.com/m6/p/drpx878c\" target=\"_blank\">Conference call </a>on Nov. 6 at 10:00 AM PT.</li> <li>Previously: <a href=\"https://seekingalpha.com/news/3405472-sabra-health-care-misses-0_02-misses-revenue\" target=\"_blank\">Sabra Health Care misses by $0.02, misses on revenue</a> (Nov. 5)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3405479\" data-linked=\"Sabra Health Care REIT sinks 3.2% after cutting guidance on lease termination\" data-tweet=\"$SBRA - Sabra Health Care REIT sinks 3.2% after cutting guidance on lease termination https://seekingalpha.com/news/3405479-sabra-health-care-reit-sinks-3_2-after-cutting-guidance-on-lease-termination?source=tweet\" data-url=\"https://seekingalpha.com/news/3405479-sabra-health-care-reit-sinks-3_2-after-cutting-guidance-on-lease-termination\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:01 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3405453\" data-ts=\"1541454470\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OXY\" target=\"_blank\">OXY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3405453-occidental-petroleumplus-1_5-after-strong-q3-earnings-revenue-beats\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Occidental Petroleum +1.5% after strong Q3 earnings, revenue beats</a></h4><ul>\n<li>Occidental Petroleum (NYSE:<a href='https://seekingalpha.com/symbol/OXY' title='Occidental Petroleum Corporation'>OXY</a>) <font color=\"green\">+1.5%</font> after-hours following news of much better than expected <a href=\"https://seekingalpha.com/news/3405387-occidental-petroleum-beats-0_23-beats-revenue\" target=\"_blank\">Q3 earnings</a> and revenues, which doubled Y/Y to $6.2B.</li>\n<li>OXY says all its business segments exceeded key performance targets through production growth in the most profitable areas, lower unit costs and better price realizations.</li>\n<li>Q3 total production volumes rose 6.5% Q/Q to 681K boe/day, while Permian Resources production volumes improved 12% Q/Q and 60% Y/Y to 225K boe/day due to improved well performance and development activity.</li>\n<li>Q3 midstream and marketing pre-tax income totaled $1.7B vs. $250M for Q2, reflecting record earnings in the marketing business as it earned higher marketing margins from improved crude oil spreads; OXY also recorded a ~$900M pre-tax net gain on the sale of domestic midstream assets in the quarter.</li>\n<li>The Chemical segment reported $321M in pre-tax income for Q3, another quarter of record earnings.</li>\n<li>OXY says its Q3 $2.6B in cash flow from operations before working capital exceeded capex and dividends by $700M.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3405453\" data-linked=\"Occidental Petroleum +1.5% after strong Q3 earnings, revenue beats\" data-tweet=\"$OXY - Occidental Petroleum +1.5% after strong Q3 earnings, revenue beats https://seekingalpha.com/news/3405453-occidental-petroleumplus-1_5-after-strong-q3-earnings-revenue-beats?source=tweet\" data-url=\"https://seekingalpha.com/news/3405453-occidental-petroleumplus-1_5-after-strong-q3-earnings-revenue-beats\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:47 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3405447\" data-ts=\"1541454265\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RNG\" target=\"_blank\">RNG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3405447-ringcentralplus-5_4-after-beat-and-raise-in-q3\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">RingCentral +5.4% after beat-and-raise in Q3</a></h4><ul>   <li>RingCentral (NYSE:<a href='https://seekingalpha.com/symbol/RNG' title='RingCentral, Inc.'>RNG</a>) has <font color=\"green\">gained 5.4%</font> postmarket after its top and bottom line beat expectations in Q3 and it boosted full-year guidance.</li>    <li>Revenues grew by a third, and subscriptions revenue by 32%.</li>    <li>Meanwhile annualized exit monthly recurring subscriptions &#40;ARR&#41; rose 31% to $674M; RingCentral Office ARR rose 36% to $592M. Mid-market and enterprise ARR rose 75%, to $270M, as enterprise ARR more than doubled to $146M.</li>    <li>That's \"excellent,\" says founder, Chairman and CEO Vlad Shmunis. \"Our mid-market and enterprise businesses continue to lead the way supported by momentum from our channel partners ... we believe we are well positioned to achieve our goal of exceeding $1 billion in revenue in 2020.\u201d</li>    <li>For Q4, it's guiding to revenue of $179M-$182M (27-29% growth, and above consensus for $175.6M), operating margin of 7.9-8.1%, and EPS of $0.17-$0.19 (vs. an expected $0.17).</li>    <li>For the full year, it's raising guidance on revenues to $664M-$667M from $649M-$656M (and topping consensus for $653.6M), operating margin to 8.4% (up from a prior 8.2-8.4%), and EPS of $0.71-$0.73 (up from $0.66-$0.70, and above consensus for $0.68).</li>    <li>\n<a href=\"http://ir.ringcentral.com/\" target=\"_blank\">Conference call</a> to come at 5 p.m. ET.</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3405330-ringcentral-beats-0_03-beats-revenue\" target=\"_blank\">RingCentral beats by $0.03, beats on revenue</a> (Nov. 05 2018)</li>    <li><a href=\"https://seekingalpha.com/pr/17322956-ringcentral-announces-third-quarter-2018-results\" target=\"_blank\">Press release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3405447\" data-linked=\"RingCentral +5.4% after beat-and-raise in Q3\" data-tweet=\"$RNG - RingCentral +5.4% after beat-and-raise in Q3 https://seekingalpha.com/news/3405447-ringcentralplus-5_4-after-beat-and-raise-in-q3?source=tweet\" data-url=\"https://seekingalpha.com/news/3405447-ringcentralplus-5_4-after-beat-and-raise-in-q3\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:44 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3405442\" data-ts=\"1541454002\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LDL\" target=\"_blank\">LDL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3405442-lydall-misses-0_13-revenue-in-line\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Lydall misses by $0.13,  revenue in-line</a></h4><ul>\n<li>Lydall (NYSE:<a href='https://seekingalpha.com/symbol/LDL' title='Lydall, Inc.'>LDL</a>): Q3 Non-GAAP EPS of $0.54 <span style=\"color:red\">misses by $0.13</span>; GAAP EPS of $0.36 <span style=\"color:red\">misses by $0.19</span>.</li>\n<li>Revenue of $197.89M (+9.9% Y/Y) in-line.</li>\n<li>Shares <font color=\"green\">+2.68%</font>.</li>\n<li><a href=\"https://seekingalpha.com/pr/17323135-lydall-announces-financial-results-third-quarter-ended-september-30-2018\">Press Release</a></li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3405442\" data-linked=\"Lydall misses by $0.13,  revenue in-line\" data-tweet=\"$LDL - Lydall misses by $0.13, revenue in-line https://seekingalpha.com/news/3405442-lydall-misses-0_13-revenue-in-line?source=tweet\" data-url=\"https://seekingalpha.com/news/3405442-lydall-misses-0_13-revenue-in-line\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:40 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3405438\" data-ts=\"1541453972\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MAR\" target=\"_blank\">MAR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3405438-marriott-internationalminus-3-after-mixed-q3\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Marriott International -3% after mixed Q3</a></h4><ul>\n<li>Marriott International (NYSE:<a href='https://seekingalpha.com/symbol/MAR' title='Marriott International, Inc.'>MAR</a>) is <font color=\"red\">down 3%</font> in AH trading after falling short with its Q3 revenue tally.</li>\n<li>The company reports Q3 comparable systemwide constant dollar RevPAR rose 1.9 percent globally, consisting of a 5.4 % jump outside North America and 0.6% rise in North America. Fee revenue was up 13% to $932M to top the expectation for a mark of $920M.</li>\n<li>Looking ahead, the company sees full-year EBITDA of $3.46B to $3.47B vs. $3.48B consensus.</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3405420-marriott-beats-0_39-misses-revenue\" target=\"_blank\">Marriott beats by $0.39, misses on revenue</a> (Nov. 5)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3405438\" data-linked=\"Marriott International -3% after mixed Q3\" data-tweet=\"$MAR - Marriott International -3% after mixed Q3 https://seekingalpha.com/news/3405438-marriott-internationalminus-3-after-mixed-q3?source=tweet\" data-url=\"https://seekingalpha.com/news/3405438-marriott-internationalminus-3-after-mixed-q3\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:39 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3405419\" data-ts=\"1541453564\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ELF\" target=\"_blank\">ELF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3405419-post-earnings-rip-for-e-l-f-beauty\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Post-earnings rip for e.l.f. Beauty</a></h4><ul>\n<li>Shares of e.l.f. Beauty (NYSE:<a href='https://seekingalpha.com/symbol/ELF' title='e.l.f. Beauty'>ELF</a>) are <font color=\"green\">up 20.5%</font> in AH trading after the company tops estimates with its Q3 report.</li>\n<li>Despite a drop in sales for the quarter, e.l.f's gross margin rate improved to 61% of sales from 60%.</li>\n<li>Looking ahead, the company anticipates full-year revenue growth in the low single digits and EPS $0.59 to $0.61 vs.  $0.56 to $0.61 prior outlook and $0.56 consensus.</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3405355-e-l-f-beauty-beats-0_09-beats-revenue\" target=\"_blank\">e.l.f. Beauty beats by $0.09, beats on revenue</a> (Nov. 5)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3405419\" data-linked=\"Post-earnings rip for e.l.f. Beauty\" data-tweet=\"$ELF - Post-earnings rip for e.l.f. Beauty https://seekingalpha.com/news/3405419-post-earnings-rip-for-e-l-f-beauty?source=tweet\" data-url=\"https://seekingalpha.com/news/3405419-post-earnings-rip-for-e-l-f-beauty\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:32 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3405416\" data-ts=\"1541453443\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FN\" target=\"_blank\">FN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3405416-fabrinetplus-10_5-on-q1-beats-upside-guide\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Fabrinet +10.5% on Q1 beats, upside guide</a></h4><ul>\n<li>        Fabrinet (NYSE:<a href='https://seekingalpha.com/symbol/FN' title='Fabrinet'>FN</a>) <font color=\"green\">gains 10.5% </font>after beating Q1 EPS and revenue estimates with a 6% Y/Y revenue growth. Upside Q2 guidance has revenue from $380M to $388M (consensus: $366.07M) and EPS of $0.91 to $0.94 (consensus: $0.84).</li>\n<li>               Earnings call is scheduled for 5 PM ET with a webcast available <a href=\"http://investor.fabrinet.com/\" target=\"_blank\">here</a>. </li>\n<li>               <a href=\"https://seekingalpha.com/pr/17323078-fabrinet-announces-first-quarter-fiscal-year-2019-financial-results\" target=\"_blank\">Press release</a>.   </li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3405378-fabrinet-beats-0_11-beats-revenue\" target=\"_blank\">Fabrinet beats by $0.11, beats on revenue</a> (Nov. 5)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3405416\" data-linked=\"Fabrinet +10.5% on Q1 beats, upside guide\" data-tweet=\"$FN - Fabrinet +10.5% on Q1 beats, upside guide https://seekingalpha.com/news/3405416-fabrinetplus-10_5-on-q1-beats-upside-guide?source=tweet\" data-url=\"https://seekingalpha.com/news/3405416-fabrinetplus-10_5-on-q1-beats-upside-guide\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:30 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3405391\" data-ts=\"1541453044\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INFI\" target=\"_blank\">INFI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3405391-infinity-pharmaceuticals-beats-0_36\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Infinity Pharmaceuticals beats by $0.36</a></h4><ul>\n<li>Infinity Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/INFI' title='Infinity Pharmaceuticals, Inc.'>INFI</a>): Q3 GAAP EPS of $0.23 <span style=\"color:green\">beats by $0.36</span>.</li>\n<li>Revenue of $22M (+3566.7% Y/Y)</li>\n<li>Shares <font color=\"green\">+7.98%</font>.</li>\n<li><a href=\"https://seekingalpha.com/pr/17322958-infinity-pharmaceuticals-provides-company-update-third-quarter-2018-financial-results\">Press Release</a></li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3405391\" data-linked=\"Infinity Pharmaceuticals beats by $0.36\" data-tweet=\"$INFI - Infinity Pharmaceuticals beats by $0.36 https://seekingalpha.com/news/3405391-infinity-pharmaceuticals-beats-0_36?source=tweet\" data-url=\"https://seekingalpha.com/news/3405391-infinity-pharmaceuticals-beats-0_36\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:24 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3405387\" data-ts=\"1541452978\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OXY\" target=\"_blank\">OXY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3405387-occidental-petroleum-beats-0_23-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Occidental Petroleum beats by $0.23, beats on revenue</a></h4><ul>\n<li>Occidental Petroleum (NYSE:<a href='https://seekingalpha.com/symbol/OXY' title='Occidental Petroleum Corporation'>OXY</a>): Q3 Non-GAAP EPS of $1.77 <span style=\"color:green\">beats by $0.23</span>; GAAP EPS of $2.44 <span style=\"color:green\">beats by $0.94</span>.</li>\n<li>Revenue of $6.2B (+100.0% Y/Y) <font color=\"green\">beats by $1.63B</font>.</li>\n<li>Shares <font color=\"green\">+1.5%</font>.</li>\n<li><a href=\"https://seekingalpha.com/pr/17323045-occidental-petroleum-announces-3rd-quarter-2018-results\">Press Release</a></li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3405387\" data-linked=\"Occidental Petroleum beats by $0.23, beats on revenue\" data-tweet=\"$OXY - Occidental Petroleum beats by $0.23, beats on revenue https://seekingalpha.com/news/3405387-occidental-petroleum-beats-0_23-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3405387-occidental-petroleum-beats-0_23-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:22 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3405382\" data-ts=\"1541452896\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AKCA\" target=\"_blank\">AKCA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3405382-akcea-q3-revenues-up-94-no-tegsedi-sales-shares-down-2-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Akcea Q3 revenues up 94% but no Tegsedi sales; shares down 2% after hours</a></h4><ul> <li>Akcea Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/AKCA' title='Akcea Therapeutics'>AKCA</a>) Q3 results ($M): Revenue: 19.2 (+93.9%) (license and R&amp;D). No TEGSEDI sales yet.</li> <li>Net loss: (63.6) (-261.4%); loss/share: (0.73) (-121.2%).</li> <li>Shares are down <font color=\"red\">2%</font> after hours.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3405382\" data-linked=\"Akcea Q3 revenues up 94% but no Tegsedi sales; shares down 2% after hours\" data-tweet=\"$AKCA - Akcea Q3 revenues up 94% but no Tegsedi sales; shares down 2% after hours https://seekingalpha.com/news/3405382-akcea-q3-revenues-up-94-no-tegsedi-sales-shares-down-2-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3405382-akcea-q3-revenues-up-94-no-tegsedi-sales-shares-down-2-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:21 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3405379\" data-ts=\"1541452888\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AKCA\" target=\"_blank\">AKCA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3405379-akcea-q3-revenues-up-94-no-tegsedi-sales-shares-down-2-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Akcea Q3 revenues up 94% but no Tegsedi sales; shares down 2% after hours</a></h4><ul>\n<li>Akcea Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/AKCA' title='Akcea Therapeutics'>AKCA</a>) Q3 results ($M): Revenue: 19.2 (+93.9%) (license and R&amp;D). No TEGSEDI sales yet.</li>\n<li>Net loss: (63.6) (-261.4%); loss/share: (0.73) (-121.2%).</li>\n<li>Shares are down <font color=\"red\">2%</font> after hours.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3405379\" data-linked=\"Akcea Q3 revenues up 94% but no Tegsedi sales; shares down 2% after hours\" data-tweet=\"$AKCA - Akcea Q3 revenues up 94% but no Tegsedi sales; shares down 2% after hours https://seekingalpha.com/news/3405379-akcea-q3-revenues-up-94-no-tegsedi-sales-shares-down-2-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3405379-akcea-q3-revenues-up-94-no-tegsedi-sales-shares-down-2-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:21 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3405377\" data-ts=\"1541452855\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/P\" target=\"_blank\">P</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3405377-pandoraplus-2_2-on-double-digit-revenue-gains-in-q3\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pandora +2.2% on double-digit revenue gains in Q3</a></h4><ul>   <li>Pandora Media (NYSE:<a href='https://seekingalpha.com/symbol/P' title='Pandora Media'>P</a>) is <font color=\"green\">up 2.2%</font> after hours after its Q3 revenues grew by double digits and beat expectations.</li>    <li>Ad revenue marked its first Y/Y growth (6%) since Q3 2017.</li>    <li>Non-GAAP gross profit was up to $160.2M from $131.7M; margins were up 500 basis points sequentially to 38%.</li>    <li>Net loss shrank to $15.5M from $15.9M.</li>    <li>Revenue breakout: Subscription, $125.8M (up 49%); Advertising, $291.9M (up 5.8%).</li>    <li>Ad RPM grew 11% to an all-time high $77.83.</li>    <li>Active users were 68.8M as of quarter's end, and total listener hours for the quarter hit 4.81B.</li>    <li>Pandora Plus and Pandora Premium subs were at 6.8M (net adds of 784,000), and more than 32M listeners have used Premium Access since its launch.</li>    <li>Cash at quarter's end was $387.6M, down from $420.8M last quarter.</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3405317-pandora-media-beats-0_05-beats-revenue\" target=\"_blank\">Pandora Media beats by $0.05, beats on revenue</a> (Nov. 05 2018)</li>    <li><a href=\"https://seekingalpha.com/pr/17322941-pandora-reports-q3-2018-financial-results\" target=\"_blank\">Press release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3405377\" data-linked=\"Pandora +2.2% on double-digit revenue gains in Q3\" data-tweet=\"$P - Pandora +2.2% on double-digit revenue gains in Q3 https://seekingalpha.com/news/3405377-pandoraplus-2_2-on-double-digit-revenue-gains-in-q3?source=tweet\" data-url=\"https://seekingalpha.com/news/3405377-pandoraplus-2_2-on-double-digit-revenue-gains-in-q3\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:20 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>28&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3405355\" data-ts=\"1541452466\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ELF\" target=\"_blank\">ELF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3405355-e-l-f-beauty-beats-0_09-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">e.l.f. Beauty beats by $0.09, beats on revenue</a></h4><ul>\n<li>e.l.f. Beauty (NYSE:<a href='https://seekingalpha.com/symbol/ELF' title='e.l.f. Beauty'>ELF</a>): Q3 Non-GAAP EPS of $0.17 <span style=\"color:green\">beats by $0.09</span>; GAAP EPS of $0.08 <span style=\"color:green\">beats by $0.06</span>.</li>\n<li>Revenue of $63.89M (-11.1% Y/Y) <font color=\"green\">beats by $3.77M</font>.</li>\n<li>Shares <font color=\"green\">+10.27%</font>.</li>\n<li><a href=\"https://seekingalpha.com/pr/17322990-e-l-f-beauty-announces-third-quarter-2018-results\">Press Release</a></li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3405355\" data-linked=\"e.l.f. Beauty beats by $0.09, beats on revenue\" data-tweet=\"$ELF - e.l.f. Beauty beats by $0.09, beats on revenue https://seekingalpha.com/news/3405355-e-l-f-beauty-beats-0_09-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3405355-e-l-f-beauty-beats-0_09-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:14 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3405351\" data-ts=\"1541452439\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MYL\" target=\"_blank\">MYL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3405351-mylan-q3-top-line-off-4-earnings-up-100-shares-up-5-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Mylan Q3 top line off 4%; earnings up 100%; shares up 5% after hours</a></h4><ul>\n<li>Mylan N.V. (NASDAQ:<a href='https://seekingalpha.com/symbol/MYL' title='Mylan Inc'>MYL</a>) <a href=\"https://seekingalpha.com/pr/17322952-mylan-reports-third-quarter-2018-results-reaffirms-2018-guidance\" target=\"_blank\">Q3 results</a> ($M): Revenues: 2,862.4 (-4.2%).</li>\n<li>North America sales down 13.6% to $1,012.3M.</li>\n<li>Net income: 176.7 (+100.1%); non-GAAP net income: 648.0 (+9.9%); EPS: 0.34 (+112.5%); non-GAAP EPS; 1.25 (+13.6%).</li>\n<li>Cash flow ops (9 mo.): $1.71B (+8.9%).</li>\n<li>2018 guidance remains as is.</li>\n<li>Shares are up <font color=\"green\">5%</font> after hours.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3405351\" data-linked=\"Mylan Q3 top line off 4%; earnings up 100%; shares up 5% after hours\" data-tweet=\"$MYL - Mylan Q3 top line off 4%; earnings up 100%; shares up 5% after hours https://seekingalpha.com/news/3405351-mylan-q3-top-line-off-4-earnings-up-100-shares-up-5-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3405351-mylan-q3-top-line-off-4-earnings-up-100-shares-up-5-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:13 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3405345\" data-ts=\"1541452367\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BKNG\" target=\"_blank\">BKNG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3405345-booking-holdingsplus-8-after-earnings\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Booking Holdings +8% after earnings</a></h4><ul> <li>Booking Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/BKNG' title='Booking Holdings Inc.'>BKNG</a>) reports gross bookings growth of 11.5% in Q3 to $24.27B/</li> <li>The company says agency revenue was $3.54B during the quarter and merchant revenue was $1.05B.</li>\n<li>EBITDA came in at $2.36B vs. $2.39B consensus.</li>  <li>Hotel nights were up 13.4% during the quarter, while airline tickers rose 9.2%.</li>  <li>Looking ahead, Booking expects Q4 total gross bookings growth of 10% to 13% and non-GAAP net income of $880M to $905M ($18.90 to $19.40 per share).</li>    <li>Shares of Booking Holdings are <font color=\"green\">up 7.69%</font> AH trading to $2,020.17.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3405345\" data-linked=\"Booking Holdings +8% after earnings\" data-tweet=\"$BKNG - Booking Holdings +8% after earnings https://seekingalpha.com/news/3405345-booking-holdingsplus-8-after-earnings?source=tweet\" data-url=\"https://seekingalpha.com/news/3405345-booking-holdingsplus-8-after-earnings\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:12 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>16&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3405314\" data-ts=\"1541451484\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NS\" target=\"_blank\">NS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3405314-nustar-energyplus-6-after-beating-q3-revenue-estimates\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">NuStar Energy +6% after beating Q3 revenue estimates</a></h4><ul>\n<li>NuStar Energy (<a href='https://seekingalpha.com/symbol/NS' title='NuStar Energy L.P.'>NS</a> <font color='green'>+6.3%</font>) surges after <a href=\"https://seekingalpha.com/news/3405007-nustar-beats-revenue\" target=\"_blank\">Q3 earnings</a> missed estimates but topped expectations on revenues, which rose +11% Y/Y to $490M.</li>\n<li>Q3 unadjusted earnings were a net loss of $3.49/unit due to a one-time $377M non-cash charge related to the recent completion of the merger of NuStar GP Holdings and NuStar Energy, which did not impact net income, EBITDA or distributable cash flow; adjusted Q3 earnings per unit was $0.13.</li>\n<li>NS says the distribution coverage ratio was 1.38x for the quarter and 1.42x for the nine months ended Sept. 30.</li>\n<li>NS cites a volume ramp-up in the Permian Crude System and significant contributions from its East Pipeline System following asset acquisitions for its strong Q3 results, and says its FY 2018 Permian Crude exit rate remains on pace for 360K-380K bbl/day.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3405314\" data-linked=\"NuStar Energy +6% after beating Q3 revenue estimates\" data-tweet=\"$NS - NuStar Energy +6% after beating Q3 revenue estimates https://seekingalpha.com/news/3405314-nustar-energyplus-6-after-beating-q3-revenue-estimates?source=tweet\" data-url=\"https://seekingalpha.com/news/3405314-nustar-energyplus-6-after-beating-q3-revenue-estimates\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:58 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3405311\" data-ts=\"1541451183\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MO\" target=\"_blank\">MO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3405311-e-cigs-no-effect-on-lowering-teen-cigarette-use-study\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">E-cigs have no effect on lowering teen cigarette use - study</a></h4><ul> <li>Reuters <a href=\"https://in.reuters.com/article/us-health-kids-e-cigarettes/teen-vapers-smoke-just-as-much-as-youth-who-dont-use-e-cigarettes-idINKCN1NA2I4?feedType=RSS&amp;feedName=health&amp;utm_source=Twitter&amp;utm_medium=Social&amp;utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29\" target=\"_blank\">reports </a>that a recent study showed that adolescents who used e-cigarettes were just as likely to eventually smoke traditional cigarettes as those who never tried vaping. Instead of reducing the amount of combustible tobacco use by teens, e-cig use actually increases the likelihood that they will light up.</li> <li>The initial phase of the study surveyed 6,258 high school students in Southern California and Connecticut about their vaping and smoking usage. About 14 - 17% had used traditional cigarettes while 23 - 29% had tried e-cigs.</li> <li>When surveyed again a year later, 7% of young people who had never tried traditional cigarettes were smoking compared to 21% who had been using e-cigs. The ones with e-cig experience were more than four times as likely to be experimenting with traditional cigarettes or smoking one-two days each month. The ones consuming both types were more likely to continue doing so.</li> <li>Selected tickers: (<a href='https://seekingalpha.com/symbol/MO' title='Altria Group, Inc.'>MO</a> <font color=\"green\">+1.3%</font>)(<a href='https://seekingalpha.com/symbol/BTI' title='British American Tobacco p.l.c. &#40;American Depository Receipts&#41;'>BTI</a> <font color=\"green\">+1.5%</font>)(<a href='https://seekingalpha.com/symbol/TPB' title='Turning Point Brands'>TPB</a> <font color=\"green\">+1.8%</font>)(<a href='https://seekingalpha.com/symbol/GLLA' title='Gilla, Inc.'>OTCPK:GLLA</a> <font color=\"red\">-3.3%</font>)(<a href='https://seekingalpha.com/symbol/IMBBY' title='Imperial Brands PLC ADR'>OTCQX:IMBBY</a> <font color=\"green\">+2%</font>)(<a href='https://seekingalpha.com/symbol/AHII' title='American Heritage International Inc.'>OTC:AHII</a>)(<a href='https://seekingalpha.com/symbol/PM' title='Philip Morris International Inc.'>PM</a> <font color=\"green\">+0.8%</font>)(<a href='https://seekingalpha.com/symbol/VGR' title='Vector Group Ltd.'>VGR</a> <font color=\"green\">+0.5%</font>)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3405311\" data-linked=\"E-cigs have no effect on lowering teen cigarette use - study\" data-tweet=\"$MO $MO $BTI - E-cigs have no effect on lowering teen cigarette use - study https://seekingalpha.com/news/3405311-e-cigs-no-effect-on-lowering-teen-cigarette-use-study?source=tweet\" data-url=\"https://seekingalpha.com/news/3405311-e-cigs-no-effect-on-lowering-teen-cigarette-use-study\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:53 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>53&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3405306\" data-ts=\"1541450265\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PTR\" target=\"_blank\">PTR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3405306-chinas-cnpc-sinopec-to-speed-up-oil-gas-drilling-to-raise-production\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">China&#39;s CNPC, Sinopec to speed up oil, gas drilling to raise production</a></h4><ul>\n<li>China National Petroleum (<a href='https://seekingalpha.com/symbol/PTR' title='PetroChina Company Limited'>PTR</a> <font color='green'>+2.3%</font>) and Sinopec (<a href='https://seekingalpha.com/symbol/SNP' title='China Petroleum & Chemical Corporation'>SNP</a> <font color='green'>+3.8%</font>) are <a href=\"https://www.reuters.com/article/us-china-oil-production/chinas-sinopec-cnpc-speed-up-oil-gas-drilling-to-boost-output-idUSKCN1NA0EG\" target=\"_blank\">speeding up drilling and exploration</a> from major tight and shale oil and gas formations in the country\u2019s western regions to increase domestic production, Reuters reports.</li>\n<li>New exploration in shale gas, tight oil and tight gas will lead to growth in production, CNPC says in its official newspaper, adding that the drilling cycle at the Mahu field in Xinjiang, one of the group's largest findings in recent years, fell 40% from a year ago, implying that oil wells are being completed and produced at a faster rate.</li>\n<li>SNP says in its own publication that it plans to tap 66 new natural gas wells and install 23 gas drilling stations during winter to increase supplies from its fields in southwestern China.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3405306\" data-linked=\"China&#39;s CNPC, Sinopec to speed up oil, gas drilling to raise production\" data-tweet=\"$PTR $PTR $SNP - China&#39;s CNPC, Sinopec to speed up oil, gas drilling to raise production https://seekingalpha.com/news/3405306-chinas-cnpc-sinopec-to-speed-up-oil-gas-drilling-to-raise-production?source=tweet\" data-url=\"https://seekingalpha.com/news/3405306-chinas-cnpc-sinopec-to-speed-up-oil-gas-drilling-to-raise-production\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:37 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3405303\" data-ts=\"1541449580\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IONS\" target=\"_blank\">IONS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3405303-akcea-up-6-ahead-of-q3-report\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Akcea up 6% ahead of Q3 report</a></h4><ul>\n<li>Ionis Pharmaceuticals (<a href='https://seekingalpha.com/symbol/IONS' title='Ionis Pharmaceuticals, Inc.'>IONS</a> <font color=\"green\">+0.8%</font>) affiliate Akcea Therapeutics (<a href='https://seekingalpha.com/symbol/AKCA' title='Akcea Therapeutics'>AKCA</a> <font color=\"green\">+6%</font>) is up on average volume ahead to its Q3 results, to be released after the close. Investors will be keenly interested in the sales numbers for hATTR med TEGSEDI (inotersen), approved in Europe in July.</li>\n<li>Consensus view is a loss/share of ($0.80) on revenue of $16.8M.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3405303\" data-linked=\"Akcea up 6% ahead of Q3 report\" data-tweet=\"$IONS $IONS $AKCA - Akcea up 6% ahead of Q3 report https://seekingalpha.com/news/3405303-akcea-up-6-ahead-of-q3-report?source=tweet\" data-url=\"https://seekingalpha.com/news/3405303-akcea-up-6-ahead-of-q3-report\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:26 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3405302\" data-ts=\"1541449424\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XM\" target=\"_blank\">XM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3405302-surveymonkey-competitor-sets-ipo-price-range\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">SurveyMonkey competitor sets IPO price range</a></h4><ul> <li>Qualtrics (<a href='https://seekingalpha.com/symbol/XM' title='Qualtrics International'>XM</a>) <a href=\"https://www.sec.gov/Archives/edgar/data/1747748/000162828018013537/qualtricss-1a2.htm\" target=\"_blank\">sets</a> an $18 to $21 price range for its IPO, which is about twice its original goal of raising $200M. The range could also double the $2.5B valuation the startup had at its last private funding round.</li> <li>In the first six months of this year, Qualtrics reported a loss of $3.4M on $184.2M in revenue. In last year\u2019s period, the loss was $3.7M on $121.4M in revenue.</li> <li>Competitor SurveyMonkey (NASDAQ:<a href='https://seekingalpha.com/symbol/SVMK' title='SurveyMonkey'>SVMK</a>) is <font color=\"red\">down 3.1%</font> to $11.21.</li>  <li>Previously: <a href=\"https://seekingalpha.com/news/3399035-surveymonkey-drops-competitor-files-200m-ipo\" target=\"_blank\">SurveyMonkey drops as competitor files for $200M IPO</a> (Oct. 19)</li>\n<li>Post updated to add more details about the pricing.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3405302\" data-linked=\"SurveyMonkey competitor sets IPO price range\" data-tweet=\"$XM $XM $SVMK - SurveyMonkey competitor sets IPO price range https://seekingalpha.com/news/3405302-surveymonkey-competitor-sets-ipo-price-range?source=tweet\" data-url=\"https://seekingalpha.com/news/3405302-surveymonkey-competitor-sets-ipo-price-range\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:23 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3405300\" data-ts=\"1541449110\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TARO\" target=\"_blank\">TARO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3405300-taro-halted-pending-news\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Taro halted pending news</a></h4><ul><li>Nasdaq has suspended trading in Taro Pharmaceutical Industries (<a href='https://seekingalpha.com/symbol/TARO' title='Taro Pharmaceutical Industries Ltd'>TARO</a> <font color=\"red\">-0.7%</font>) pending the release of news. The company will release fiscal Q2 results after the close.</li></ul><div class=\"tiny-share-widget\" data-id=\"3405300\" data-linked=\"Taro halted pending news\" data-tweet=\"$TARO - Taro halted pending news https://seekingalpha.com/news/3405300-taro-halted-pending-news?source=tweet\" data-url=\"https://seekingalpha.com/news/3405300-taro-halted-pending-news\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:18 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3405299\" data-ts=\"1541449084\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CCJ\" target=\"_blank\">CCJ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3405299-cameco-says-still-cautious-amid-improved-uranium-market\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cameco says still cautious amid improved uranium market</a></h4><ul>\n<li>The uranium market has showed a \u201cmarked\u201d improved over the past year, Cameco (<a href='https://seekingalpha.com/symbol/CCJ' title='Cameco Corporation'>CCJ</a> <font color='green'>+9%</font>) CEO Tim Gitzel says while cautioning that prices are still <a href=\"http://www.miningweekly.com/article/cameco-says-uranium-market-improves-but-still-a-need-for-caution-2018-11-05\" target=\"_blank\">\"nowhere near\" the level needed</a> to restart idled production  capacity or consider new production opportunities.</li>\n<li>Gitzel sees steady growth in demand, with 55 reactors under construction,  but long-term opportunities are not yet acceptable to return suspended  capacity to the market.</li>\n<li>CCJ, which in July indefinitely suspended its McArthur River/Key Lake operations in Saskatchewan, reported better than expected <a href=\"https://seekingalpha.com/news/3404729-cameco-beats-c-0_05-misses-revenue\" target=\"_blank\">Q3 earnings</a> last Friday.</li>\n<li>Significant production cuts, reductions in producer inventories and an  increase in demand for uranium in the spot market have put pressure on  uranium prices, with the current spot price up ~40% Y/Y; uranium hit $28.75/lb. on Friday, its <a href=\"https://www.ft.com/content/a38cdbcc-e0ed-11e8-8e70-5e22a430c1ad\" target=\"_blank\">highest level since March 2016</a>.</li>\n<li>Other uranium producers also trade higher: <a href='https://seekingalpha.com/symbol/UUUU' title='Energy Fuels Inc'>UUUU</a> <font color=\"green\">+15%</font>, <a href='https://seekingalpha.com/symbol/UEC' title='Uranium Energy Corp'>UEC</a> <font color=\"green\">+6%</font>, <a href='https://seekingalpha.com/symbol/URG' title='Ur-Energy Inc.'>URG</a> <font color=\"green\">+7.9%</font>.</li>\n<li>ETFs: <a href='https://seekingalpha.com/symbol/URA' title='Global X Uranium ETF'>URA</a>, <a href='https://seekingalpha.com/symbol/NLR' title='VanEck Vectors Uranium+Nuclear Energy ETF'>NLR</a></li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3405299\" data-linked=\"Cameco says still cautious amid improved uranium market\" data-tweet=\"$CCJ $CCJ $UUUU - Cameco says still cautious amid improved uranium market https://seekingalpha.com/news/3405299-cameco-says-still-cautious-amid-improved-uranium-market?source=tweet\" data-url=\"https://seekingalpha.com/news/3405299-cameco-says-still-cautious-amid-improved-uranium-market\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:18 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>16&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3405295\" data-ts=\"1541448002\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DWCH\" target=\"_blank\">DWCH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3405295-dwch-jks-altr-and-tdoc-tops-tech-movers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">DWCH, JKS, ALTR and TDOC tops tech movers</a></h4><ul> <li>\n<strong>Gainers: </strong>Datawatch Corporation (NASDAQ:<a href='https://seekingalpha.com/symbol/DWCH' title='Datawatch Corporation'>DWCH</a>) <font color=\"green\">+35%</font>. JinkoSolar Holding Co., Ltd. (NYSE:<a href='https://seekingalpha.com/symbol/JKS' title='JinkoSolar Holding Co., Ltd.'>JKS</a>) <font color=\"green\">+19%</font>. Sequans Communications S.A. (NYSE:<a href='https://seekingalpha.com/symbol/SQNS' title='Sequans Communications'>SQNS</a>) <font color=\"green\">+12%</font>. Diebold Nixdorf, Incorporated (NYSE:<a href='https://seekingalpha.com/symbol/DBD' title='Diebold Nixdorf'>DBD</a>) <font color=\"green\">+9%</font>. VirTra, Inc. (NASDAQ:<a href='https://seekingalpha.com/symbol/VTSI' title='VirTra, Inc.'>VTSI</a>) <font color=\"green\">+9%</font>.</li> <li>\n<strong>Losers: </strong>Altair Engineering (NASDAQ:<a href='https://seekingalpha.com/symbol/ALTR' title='Altair Engineering, Inc.  Cl A'>ALTR</a>) <font color=\"red\">-18%</font>. Teladoc Health (NYSE:<a href='https://seekingalpha.com/symbol/TDOC' title='Teladoc Health, Inc.'>TDOC</a>) <font color=\"red\">-12%</font>. FTE Networks (NYSEMKT:<a href='https://seekingalpha.com/symbol/FTNW' title='FTE Networks, Inc.'>FTNW</a>) <font color=\"red\">-10%</font>. United Microelectronics (NYSE:<a href='https://seekingalpha.com/symbol/UMC' title='United Microelectronics Corporation'>UMC</a>) <font color=\"red\">-8%</font>. FormFactor (NASDAQ:<a href='https://seekingalpha.com/symbol/FORM' title='FormFactor, Inc.'>FORM</a>) <font color=\"red\">-8%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3405295\" data-linked=\"DWCH, JKS, ALTR and TDOC tops tech movers\" data-tweet=\"$DWCH $DWCH $JKS - DWCH, JKS, ALTR and TDOC tops tech movers https://seekingalpha.com/news/3405295-dwch-jks-altr-and-tdoc-tops-tech-movers?source=tweet\" data-url=\"https://seekingalpha.com/news/3405295-dwch-jks-altr-and-tdoc-tops-tech-movers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3405292\" data-ts=\"1541447521\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3405292-s-and-p-gains-while-apple-leads-nasdaq-lower\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">S&amp;P gains, while Apple leads Nasdaq lower</a></h4><ul> <li>A bit more than an hour before the closing bell, the S&amp;P 500 is <font color=\"green\">higher by 0.7%</font> and Dow <font color=\"green\">by 0.9%</font>. Led by a <font color=\"red\">3% decline</font> for Apple, and roughly <font color=\"red\">2% dips </font>for Amazon and Google, the Nasdaq is <font color=\"red\">down 0.3%</font>.</li> <li>Apple has now <font color=\"red\">given back about 10%</font> since reporting earnings on Thursday evening.</li> <li>Excepting those three big tech names, it's a pretty broad rally, with financials and healthcare among S&amp;P sectors sporting <font color=\"green\">1%+ gains</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3405292\" data-linked=\"S&amp;P gains, while Apple leads Nasdaq lower\" data-tweet=\"S&amp;P gains, while Apple leads Nasdaq lower https://seekingalpha.com/news/3405292-s-and-p-gains-while-apple-leads-nasdaq-lower?source=tweet\" data-url=\"https://seekingalpha.com/news/3405292-s-and-p-gains-while-apple-leads-nasdaq-lower\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:52 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3405291\" data-ts=\"1541447250\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RDC\" target=\"_blank\">RDC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3405291-rowan-to-reactivate-stacked-drillship-after-winning-total-contract-award\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Rowan to reactivate stacked drillship after winning Total contract award</a></h4><ul> <li>Rowan (<a href='https://seekingalpha.com/symbol/RDC' title='Rowan Companies plc'>RDC</a> <font color=\"green\">+2.4%</font>) is higher after saying its <em>Rowan Renaissance</em> ultra-deepwater drillship has been <a href=\"https://www.offshoreenergytoday.com/rowan-to-reactivate-warm-stacked-drillship-following-total-contract-award/\" target=\"_blank\">awarded a contract</a> for work offshore Mexico by Total (<a href='https://seekingalpha.com/symbol/TOT' title='TOTAL S.A.'>TOT</a> <font color=\"green\">+2.2%</font>) with a firm term of one well with an estimated duration of 60 days and three one-well options; the dayrate is not disclosed.</li> <li>RDC says the drillship is being reactivated from warm stack offshore Louisiana.</li> <li>The block TOT operates in the Perdido Fold Basin off Mexico is believed to contain 1.44B boe in mostly light and extra light crude as well as natural gas.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3405291\" data-linked=\"Rowan to reactivate stacked drillship after winning Total contract award\" data-tweet=\"$RDC $RDC $TOT - Rowan to reactivate stacked drillship after winning Total contract award https://seekingalpha.com/news/3405291-rowan-to-reactivate-stacked-drillship-after-winning-total-contract-award?source=tweet\" data-url=\"https://seekingalpha.com/news/3405291-rowan-to-reactivate-stacked-drillship-after-winning-total-contract-award\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:47 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3405289\" data-ts=\"1541446543\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BLDR\" target=\"_blank\">BLDR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3405289-builders-firstsourceminus-7-after-evercore-gloom\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Builders FirstSource -7% after Evercore gloom</a></h4><ul>\n<li>Builders FirstSource (NASDAQ:<a href='https://seekingalpha.com/symbol/BLDR' title='Builders FirstSource, Inc.'>BLDR</a>) is <font color=\"red\">down 6.6%</font> after Evercore ISI warns that investors may assign a lower multiple to the stock due to the lower pace of new construction and see a reduced probability of M&amp;A action out of the company.</li>\n<li>The firm lines up an Underperform rating on BLDR and price target of $14.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3405289\" data-linked=\"Builders FirstSource -7% after Evercore gloom\" data-tweet=\"$BLDR - Builders FirstSource -7% after Evercore gloom https://seekingalpha.com/news/3405289-builders-firstsourceminus-7-after-evercore-gloom?source=tweet\" data-url=\"https://seekingalpha.com/news/3405289-builders-firstsourceminus-7-after-evercore-gloom\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:35 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3405286\" data-ts=\"1541446161\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SMCI\" target=\"_blank\">SMCI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3405286-super-micro-launches-new-servers-sharesminus-10\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Super Micro launches new servers; shares -10%</a></h4><ul>\n<li>        Super Micro (NASDAQ:<a href='https://seekingalpha.com/symbol/SMCI' title='Super Micro Computer, Inc.'>SMCI</a>) <a href=\"https://seekingalpha.com/pr/17322738-supermicro-boosts-entry-server-line-enabling-rich-set-new-workloads-cost-optimized-entry\" target=\"_blank\">releases</a> a new UP servers optimized for the new Intel Xeon E-2100 processors.</li>\n<li>               SMCI says the new Supermicro servers boost performance up to 50% higher than the previous gen with enhancements including improved energy efficiency, faster I/O bandwidth, increased security, 50% more processor cores, and increased performance-per-watt. </li>\n<li>               The Mainstream UP servers optimize a 6-core Xeon E processor with up to 128 GB DDR4 memory in a 1U form factor with different options for I/O and power. The 1U WIO SuperServer uses the same processor and memory with flexible storage options. The multi-node, data center focused MicroBlade systems support up to 28 nodes in 6U or 14 nodes in 3U. </li>\n<li>               SMCI shares are <font color=\"red\">down 10.1% </font>to $12.36.  </li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3402786-super-micro-denies-spy-chips-u-s-senators\" target=\"_blank\">Super Micro (again) denies spy chips to U.S. senators</a> (Oct. 30)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3405286\" data-linked=\"Super Micro launches new servers; shares -10%\" data-tweet=\"$SMCI - Super Micro launches new servers; shares -10% https://seekingalpha.com/news/3405286-super-micro-launches-new-servers-sharesminus-10?source=tweet\" data-url=\"https://seekingalpha.com/news/3405286-super-micro-launches-new-servers-sharesminus-10\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:29 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3405279\" data-ts=\"1541444531\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/UPL\" target=\"_blank\">UPL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3405279-ultra-petroleum-leads-energy-materials-gainers-while-emerge-energy-leads-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ultra Petroleum leads the Energy/Materials gainers, while Emerge Energy leads the losers</a></h4><ul>\n<li>\n<b>Gainers: </b>Ultra Petroleum (NASDAQ:<a href='https://seekingalpha.com/symbol/UPL' title='Ultra Petroleum Corp.'>UPL</a>) <font color=\"green\">+18%</font>. McDermott (NYSE:<a href='https://seekingalpha.com/symbol/MDR' title='McDermott International, Inc.'>MDR</a>) <font color=\"green\">+9%</font>. Chesapeake Energy (NYSE:<a href='https://seekingalpha.com/symbol/CHK' title='Chesapeake Energy Corporation'>CHK</a>) <font color=\"green\">+9%</font>. NuStar Energy (NYSE:<a href='https://seekingalpha.com/symbol/NS' title='NuStar Energy L.P.'>NS</a>) <font color=\"green\">+9%</font>. NexGen Energy (NYSEMKT:<a href='https://seekingalpha.com/symbol/NXE' title='Nexgen Energy Ltd.'>NXE</a>) <font color=\"green\">+8%</font>.</li>\n<li>\n<b>Losers: </b>Emerge Energy Services (NYSE:<a href='https://seekingalpha.com/symbol/EMES' title='Emerge Energy Services LP'>EMES</a>) <font color=\"red\">-19%</font>. TransAtlantic Petroleum (NYSEMKT:<a href='https://seekingalpha.com/symbol/TAT' title='TransAtlantic Petroleum Ltd.'>TAT</a>) <font color=\"red\">-10%</font>. North American Construction (NYSE:<a href='https://seekingalpha.com/symbol/NOA' title='North American Energy Partners Inc.'>NOA</a>) <font color=\"red\">-10%</font>. Smart Sand (NASDAQ:<a href='https://seekingalpha.com/symbol/SND' title='Smart Sand'>SND</a>) <font color=\"red\">-10%</font>. China Natural Resources (NASDAQ:<a href='https://seekingalpha.com/symbol/CHNR' title='China Natural Resources, Inc.'>CHNR</a>) <font color=\"red\">-9%</font>.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3405279\" data-linked=\"Ultra Petroleum leads the Energy/Materials gainers, while Emerge Energy leads the losers\" data-tweet=\"$UPL $UPLC $MDR - Ultra Petroleum leads the Energy/Materials gainers, while Emerge Energy leads the losers https://seekingalpha.com/news/3405279-ultra-petroleum-leads-energy-materials-gainers-while-emerge-energy-leads-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3405279-ultra-petroleum-leads-energy-materials-gainers-while-emerge-energy-leads-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:02 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3405275\" data-ts=\"1541443636\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NVUS\" target=\"_blank\">NVUS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3405275-novus-up-20\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Novus up 20%</a></h4><ul> <li>Thinly traded nano cap Novus Therapeutics (<a href='https://seekingalpha.com/symbol/NVUS' title='Novus Therapeutics'>NVUS</a> <font color=\"green\">+19.8%</font>) is up on below-average volume on no particular news. Two months ago, it <a href=\"https://www.sec.gov/Archives/edgar/data/1404281/000119312518268697/d620391drw.htm\" target=\"_blank\">withdrew </a>its <a href=\"https://www.sec.gov/Archives/edgar/data/1404281/000119312518266270/d582012ds1a.htm\" target=\"_blank\">registration statement</a> for a 6M-share stock offering.</li> <li>At the end of June, it had $19.2M in cash while operations consumed $5.6M in H1.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3405275\" data-linked=\"Novus up 20%\" data-tweet=\"$NVUS - Novus up 20% https://seekingalpha.com/news/3405275-novus-up-20?source=tweet\" data-url=\"https://seekingalpha.com/news/3405275-novus-up-20\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:47 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3405273\" data-ts=\"1541442700\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DFRG\" target=\"_blank\">DFRG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3405273-del-friscos-slides-after-delaying-q3-earnings-report\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Del Frisco&#39;s slides after delaying Q3 earnings report</a></h4><ul> <li>Del Frisco's Restaurant Group (<a href='https://seekingalpha.com/symbol/DFRG' title='Del Frisco&#39;s Restaurant Group'>DFRG</a> <font color='red'>-12.1%</font>) slumps after the restaurant company postpones the release of its Q3 earnings report to November 13 after originally being scheduled to release results today.</li>\n<li>The company says the postponement accommodates the additional time required to finalize the accounting and tax treatment of the acquisition of Barteca Restaurant Group, disposition of Sullivan\u2019s Steakhouse, secondary offering of common stock and debt syndication.</li>\n<li>Source: <a href=\"https://seekingalpha.com/pr/17321878-del-frisco-s-restaurant-group-inc-postpone-third-quarter-2018-earnings-release-conference\" target=\"_blank\">Press Release</a>\n</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3405273\" data-linked=\"Del Frisco&#39;s slides after delaying Q3 earnings report\" data-tweet=\"$DFRG - Del Frisco&#39;s slides after delaying Q3 earnings report https://seekingalpha.com/news/3405273-del-friscos-slides-after-delaying-q3-earnings-report?source=tweet\" data-url=\"https://seekingalpha.com/news/3405273-del-friscos-slides-after-delaying-q3-earnings-report\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:31 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3405271\" data-ts=\"1541442415\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ABBV\" target=\"_blank\">ABBV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3405271-analysts-offer-different-views-on-abbvie-shares-recoup-losses-from-fridays-reversal-up-4\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Analysts offer different views on AbbVie as shares recoup losses from Friday&#39;s reversal, up 4%</a></h4><ul> <li>AbbVie (<a href='https://seekingalpha.com/symbol/ABBV' title='AbbVie Inc.'>ABBV</a> <font color=\"green\">+4.4%</font>) is up, albeit on below-average volume, as shares recoup a good chunk of Friday's bearish reversal of almost <font color=\"red\">6%</font> from the intraday high of $84.42 as investors digest the company's prospects after its Q3 earnings call and the potential encroachment of biosimilars in Europe to top seller Humira.</li> <li>William Blair's Katherine Xu (OUTPERFORM) is leading the cheerleaders citing near-term blockbuster-potential product launches and its attractive relative valuation. She has raised her 2018 non-GAAP EPS estimate to $7.90 from $7.85 while noting the company's 11.5% dividend raise. The price target was $127 last quarter but may have changed.</li> <li>Credit Suisse's Vamil Divan is in the bearish camp (UNDERPERFORM/$79) citing the downward pressure on Humira in Europe and management's projection of a 26 - 27% drop in ex-U.S. sales next year. The outlook for Humira in the U.S. remains solid as do Imbruvica sales and gross margin assumptions.</li> <li>Bloomberg Intelligence's Sam Fazeli adds that Imbruvica is will on its way to be a mega blockbuster. Upadacitinib and risankizumab should be major growth drivers as well.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3405271\" data-linked=\"Analysts offer different views on AbbVie as shares recoup losses from Friday&#39;s reversal, up 4%\" data-tweet=\"$ABBV - Analysts offer different views on AbbVie as shares recoup losses from Friday&#39;s reversal, up 4% https://seekingalpha.com/news/3405271-analysts-offer-different-views-on-abbvie-shares-recoup-losses-from-fridays-reversal-up-4?source=tweet\" data-url=\"https://seekingalpha.com/news/3405271-analysts-offer-different-views-on-abbvie-shares-recoup-losses-from-fridays-reversal-up-4\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:26 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>37&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3405265\" data-ts=\"1541440954\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CNA\" target=\"_blank\">CNA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3405265-cna-financial-leads-financial-gainers-elevate-credit-and-elbit-imaging-among-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CNA Financial leads financial gainers; Elevate Credit and Elbit Imaging among losers</a></h4><ul>\n<li>\n<b>Gainers:</b> CNA Financial (NYSE:<a href='https://seekingalpha.com/symbol/CNA' title='CNA Financial Corporation'>CNA</a>) <font color=\"green\">+9%</font>. Oxbridge Re Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/OXBR' title='Oxbridge Re Holdings Limited'>OXBR</a>) <font color=\"green\">+7%</font>. U.S. Global Investors (NASDAQ:<a href='https://seekingalpha.com/symbol/GROW' title='U.S. Global Investors, Inc.'>GROW</a>) <font color=\"green\">+7%</font>. Provident Bancorp (NASDAQ:<a href='https://seekingalpha.com/symbol/PVBC' title='Provident Bancorp, Inc.'>PVBC</a>) <font color=\"green\">+6%</font>. Omega Healthcare Investors (NYSE:<a href='https://seekingalpha.com/symbol/OHI' title='Omega Healthcare Investors, Inc'>OHI</a>) <font color=\"green\">+6%</font>.</li> <li>\n<b>Losers:</b> China Internet Nationwide Financial Services (NASDAQ:<a href='https://seekingalpha.com/symbol/CIFS' title='China Internet Nationwide Financial Services Inc.'>CIFS</a>) <font color=\"red\">-10%</font>. Elevate Credit (NYSE:<a href='https://seekingalpha.com/symbol/ELVT' title='Elevate Credit'>ELVT</a>) <font color=\"red\">-10%</font>. Elbit Imaging (NASDAQ:<a href='https://seekingalpha.com/symbol/EMITF' title='Elbit Imaging Ltd.'>EMITF</a>) <font color=\"red\">-9%</font>. United Insurance Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/UIHC' title='United Insurance Holdings Corp.'>UIHC</a>) <font color=\"red\">-6%</font>. Maiden Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/MHLD' title='Maiden Hldgs Ltd'>MHLD</a>) <font color=\"red\">-6%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3405265\" data-linked=\"CNA Financial leads financial gainers; Elevate Credit and Elbit Imaging among losers\" data-tweet=\"$CNA $CNA $OXBR - CNA Financial leads financial gainers; Elevate Credit and Elbit Imaging among losers https://seekingalpha.com/news/3405265-cna-financial-leads-financial-gainers-elevate-credit-and-elbit-imaging-among-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3405265-cna-financial-leads-financial-gainers-elevate-credit-and-elbit-imaging-among-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:02 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3405262\" data-ts=\"1541440187\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CVX\" target=\"_blank\">CVX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3405262-chevron-extends-gains-on-credit-suisse-upgrade-after-strong-earnings\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Chevron extends gains on Credit Suisse upgrade after strong earnings</a></h4><ul>\n<li>Chevron (<a href='https://seekingalpha.com/symbol/CVX' title='Chevron Corporation'>CVX</a> <font color='green'>+3.5%</font>) enjoys strong gains after Credit Suisse <a href=\"https://www.cnbc.com/2018/11/05/chevron-shares-jump-extending-gains-on-credit-suisse-upgrade.html\" target=\"_blank\">upgrades</a> shares to Outperform from Neutral with a $138 price target and calls the company's free cash flow and the stock's valuation \"compelling.\"</li>\n<li>CVX <a href=\"https://seekingalpha.com/news/3404740-chevron-plus-2-percent-q3-earnings-top-estimates-quarterly-output-hits-record\" target=\"_blank\">last Friday</a> reported better than expected Q3 earnings and revenues and said it expects its oil and gas production to grow at the  top end of its previously forecast 4%-7% range, which should yield better capital efficiency in 2018 and boost free cash flow, Credit Suisse says.</li>\n<li>Healthier cash flow will allow CVX management to reward investors with a competitive quarterly dividend  payment and potentially expand its $3B/year share buyback  program, the firm says.</li>\n<li>CVX \"continues to execute on its already superior growth outlook,\"  even as its stock trades at a \"wider than normal\" discount to Exxon Mobil, Credit Suisse says.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3405262\" data-linked=\"Chevron extends gains on Credit Suisse upgrade after strong earnings\" data-tweet=\"$CVX - Chevron extends gains on Credit Suisse upgrade after strong earnings https://seekingalpha.com/news/3405262-chevron-extends-gains-on-credit-suisse-upgrade-after-strong-earnings?source=tweet\" data-url=\"https://seekingalpha.com/news/3405262-chevron-extends-gains-on-credit-suisse-upgrade-after-strong-earnings\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:49 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3405260\" data-ts=\"1541439996\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DWCH\" target=\"_blank\">DWCH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3405260-microcaps-mostly-among-midday-movers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Microcaps mostly among midday movers</a></h4><ul>\n<li>\n<strong>Gainers: </strong>Datawatch (NASDAQ:<a href='https://seekingalpha.com/symbol/DWCH' title='Datawatch Corporation'>DWCH</a>) <font color=\"green\">+35%</font>. JinkoSolar Holding (NYSE:<a href='https://seekingalpha.com/symbol/JKS' title='JinkoSolar Holding Co., Ltd.'>JKS</a>) <font color=\"green\">+18%</font>. Yulong Eco-Materials (NASDAQ:<a href='https://seekingalpha.com/symbol/YECO-OLD' title='Yulong Eco-Materials'>YECO-OLD</a>) <font color=\"green\">+17%</font>. Comstock Holding Companies (NASDAQ:<a href='https://seekingalpha.com/symbol/CHCI' title='Comstock Homebuilding Companies, Inc.'>CHCI</a>) <font color=\"green\">+16%</font>. Puma Biotechnology (NYSE:<a href='https://seekingalpha.com/symbol/PBYI' title='Puma Biotechnology, Inc.'>PBYI</a>) <font color=\"green\">+15%</font>. Planet Green Holdings (NYSEMKT:<a href='https://seekingalpha.com/symbol/PLAG' title='Planet Green Holdings Corp'>PLAG</a>) <font color=\"green\">+14%</font>. Nxt-ID (NASDAQ:<a href='https://seekingalpha.com/symbol/NXTD' title='NXT-ID Inc.'>NXTD</a>) <font color=\"green\">+13%</font>. Pyxus International (NYSE:<a href='https://seekingalpha.com/symbol/PYX' title='Pyxus International, Inc.'>PYX</a>) <font color=\"green\">+13%</font>. Aytu BioScience (NASDAQ:<a href='https://seekingalpha.com/symbol/AYTU' title='Aytu BioScience, Inc.'>AYTU</a>) <font color=\"green\">+12%</font>. Ceragon Networks (NASDAQ:<a href='https://seekingalpha.com/symbol/CRNT' title='Ceragon Networks Ltd.'>CRNT</a>) <font color=\"green\">+13%</font>.</li>\n<li>\n<strong>Losers: </strong>Clearside Biomedical (NASDAQ:<a href='https://seekingalpha.com/symbol/CLSD' title='Clearside Biomedical'>CLSD</a>) <font color=\"red\">-59%</font>. Welbilt (NYSE:<a href='https://seekingalpha.com/symbol/WBT' title='Welbilt, Inc.'>WBT</a>) <font color=\"red\">-25%</font>. Altair Engineering (NASDAQ:<a href='https://seekingalpha.com/symbol/ALTR' title='Altair Engineering, Inc.  Cl A'>ALTR</a>) <font color=\"red\">-19%. </font>CohBar (NASDAQ:<a href='https://seekingalpha.com/symbol/CWBR' title='CohBar Inc.'>CWBR</a>) <font color=\"red\">-18%</font>. Shineco (NASDAQ:<a href='https://seekingalpha.com/symbol/TYHT' title='Shineco, Inc.'>TYHT</a>) <font color=\"red\">-16%</font>. Emerge Energy Services (NYSE:<a href='https://seekingalpha.com/symbol/EMES' title='Emerge Energy Services LP'>EMES</a>) <font color=\"red\">-17%</font>. Synthesis Energy Systems (NASDAQ:<a href='https://seekingalpha.com/symbol/SES' title='Synthesis Energy Systems, Inc.'>SES</a>) <font color=\"red\">-17%</font>. Avadel Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/AVDL' title='Avadel Pharmaceuticals plc'>AVDL</a>) <font color=\"red\">-16%</font>. Health Insurance Innovations (NASDAQ:<a href='https://seekingalpha.com/symbol/HIIQ' title='Health Insurance Innovations'>HIIQ</a>) <font color=\"red\">-13%</font>. Minerva Neurosciences (NASDAQ:<a href='https://seekingalpha.com/symbol/NERV' title='Minerva Neurosciences'>NERV</a>) <font color=\"red\">-13%</font>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3405260\" data-linked=\"Microcaps mostly among midday movers\" data-tweet=\"$DWCH $DWCH $JKS - Microcaps mostly among midday movers https://seekingalpha.com/news/3405260-microcaps-mostly-among-midday-movers?source=tweet\" data-url=\"https://seekingalpha.com/news/3405260-microcaps-mostly-among-midday-movers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:46 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3405250\" data-ts=\"1541438743\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3405250-tech-lunch-break-big-tech-woes-weigh-on-sector\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tech lunch break: Big Tech woes weigh on sector</a></h4><ul>\n<li>        The Nasdaq 100 <font color=\"red\">drops 1.1% </font>as President Trump weighs an antitrust case against Big Tech and Alphabet and Facebook face a potential British digital services tax, which Moody\u2019s says will be \u201ccredit negative.\u201d Apple slumps on a report the company cancelled production expansion for the iPhone XR.</li>\n<li>               The Technology Select Sector SPDR Fund (NYSEARCA:<a href='https://seekingalpha.com/symbol/XLK' title='Technology Select Sector SPDR ETF'>XLK</a>)<font color=\"red\"> drops 1%,</font> the S&amp;P 500 IT index <font color=\"red\">drops 1%,</font> and the Philadelphia Semiconductor Index is <font color=\"red\">down 1.9% </font>compared to the <font color=\"red\">1%</font> Nasdaq drop and<font color=\"green\"> 0.3% gain</font> for the S&amp;P 500.   </li>\n<li>Related broad tech and semi ETFs: <a href='https://seekingalpha.com/symbol/XLK' title='Technology Select Sector SPDR ETF'>XLK</a>, <a href='https://seekingalpha.com/symbol/VGT' title='Vanguard Information Technology ETF'>VGT</a>, <a href='https://seekingalpha.com/symbol/SOXL' title='Direxion Daily Semiconductor 3x Bull Shares ETF'>SOXL</a>, <a href='https://seekingalpha.com/symbol/SOXX' title='iShares PHLX SOX Semiconductor Sector Index ETF'>SOXX</a>, <a href='https://seekingalpha.com/symbol/SMH' title='VanEck Vectors Semiconductor ETF'>SMH</a>, <a href='https://seekingalpha.com/symbol/TECL' title='Direxion Technology Bull 3x Shares ETF'>TECL</a>, <a href='https://seekingalpha.com/symbol/FTEC' title='Fidelity MSCI Information Technology Index ETF'>FTEC</a>, <a href='https://seekingalpha.com/symbol/USD' title='ProShares Ultra Semiconductors ETF'>USD</a>, <a href='https://seekingalpha.com/symbol/IYW' title='iShares U.S. Technology ETF'>IYW</a>, <a href='https://seekingalpha.com/symbol/PSI' title='Invesco Dynamic Semiconductors Portfolio ETF'>PSI</a>, <a href='https://seekingalpha.com/symbol/ROM' title='ProShares Ultra Technology ETF'>ROM</a>, <a href='https://seekingalpha.com/symbol/XSD' title='SPDR S&P Semiconductor ETF'>XSD</a>, <a href='https://seekingalpha.com/symbol/QTEC' title='First Trust NASDAQ-100-Tech Index ETF'>QTEC</a>, <a href='https://seekingalpha.com/symbol/RYT' title='Invesco S&P 500 Equal Weight Technology ETF'>RYT</a>, <a href='https://seekingalpha.com/symbol/SOXS' title='Direxion Daily Semiconductor 3x Bear Shares ETF'>SOXS</a>, <a href='https://seekingalpha.com/symbol/FNG' title='AdvisorShares New Tech and Media ETF'>FNG</a>, <a href='https://seekingalpha.com/symbol/TECS' title='Direxion Technology Bear 3x Shares ETF'>TECS</a>, <a href='https://seekingalpha.com/symbol/IGM' title='iShares North American Tech ETF'>IGM</a>, <a href='https://seekingalpha.com/symbol/FXL' title='First Trust Tech AlphaDEX ETF'>FXL</a>, <a href='https://seekingalpha.com/symbol/XNTK' title='SPDR NYSE Technology ETF'>XNTK</a>, <a href='https://seekingalpha.com/symbol/REW' title='ProShares UltraShort Technology ETF'>REW</a>, <a href='https://seekingalpha.com/symbol/SSG' title='ProShares UltraShort Semiconductors ETF'>SSG</a>, <a href='https://seekingalpha.com/symbol/FTXL' title='First Trust Nasdaq Semiconductor ETF'>FTXL</a>, <a href='https://seekingalpha.com/symbol/JHMT' title='John Hancock Multifactor Technology ETF'>JHMT</a>, <a href='https://seekingalpha.com/symbol/XITK' title='SPDR Innovative Technology ETF'>XITK</a>, <a href='https://seekingalpha.com/symbol/XTH' title='SPDR S&P Technology Hardware ETF'>XTH</a>.</li>\n<li>Top stories from the morning:</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3404969-trump-weighs-antitrust-case-big-tech\" target=\"_blank\">Trump weighs antitrust case on Big Tech</a> (Nov. 5)</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3405231-moodys-britains-digital-tax-credit-negative-alphabet-fb\" target=\"_blank\">Moody's: Britain's digital tax would be \"credit negative\" for Alphabet, FB</a> (Nov. 5)</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3405227-apple-suppliers-drop-production-expansion-halt\" target=\"_blank\">Apple suppliers drop on production expansion halt</a> (Nov. 5)</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3405238-roku-dips-morgan-stanley-hikes-target-warns-rivals\" target=\"_blank\">Roku dips as Morgan Stanley hikes target but warns on rivals</a> (Nov. 5)</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3404984-report-apple-cancels-iphone-xr-output-boost\" target=\"_blank\">Report: Apple cancels iPhone XR output boost</a> (Nov. 5)</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3405115-rosenblatt-downgrades-apple-weak-iphone-sales\" target=\"_blank\">Rosenblatt downgrades Apple on weak iPhone sales</a> (Nov. 5)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3405250\" data-linked=\"Tech lunch break: Big Tech woes weigh on sector\" data-tweet=\"$XLK $VGT $SOXL - Tech lunch break: Big Tech woes weigh on sector https://seekingalpha.com/news/3405250-tech-lunch-break-big-tech-woes-weigh-on-sector?source=tweet\" data-url=\"https://seekingalpha.com/news/3405250-tech-lunch-break-big-tech-woes-weigh-on-sector\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:25 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3405242\" data-ts=\"1541438032\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CMTL\" target=\"_blank\">CMTL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3405242-comtech-telecom-sets-new-550m-credit-facility\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Comtech Telecom sets new $550M credit facility</a></h4><ul>   <li>Comtech Telecommunications (<a href=\"http://seekingalpha.com/symbol/CMTL\" target=\"_blank\">CMTL</a> <font color=\"red\">-1.8%</font>) has set a <a href=\"https://seekingalpha.com/pr/17322718-comtech-telecommunications-corp-enters-new-550_0-million-credit-facility\" target=\"_blank\">new $550M credit facility</a> with a five-year term.</li>    <li>The new facility consists of a senior secured revolving loan with a $300M limit, and an accordion feature allowing for borrowing up to an additional $250M.</li>    <li>It intends to use funds for general purposes \"including supporting the company's growth strategies.\"</li>    <li>There's no scheduled payments of principal until maturity, the company notes, and the new facility eliminates or relaxes many restrictive covenants from the prior facility.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3405242\" data-linked=\"Comtech Telecom sets new $550M credit facility\" data-tweet=\"$CMTL - Comtech Telecom sets new $550M credit facility https://seekingalpha.com/news/3405242-comtech-telecom-sets-new-550m-credit-facility?source=tweet\" data-url=\"https://seekingalpha.com/news/3405242-comtech-telecom-sets-new-550m-credit-facility\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:13 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3405238\" data-ts=\"1541437682\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ROKU\" target=\"_blank\">ROKU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3405238-roku-dips-morgan-stanley-hikes-target-warns-on-rivals\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Roku dips as Morgan Stanley hikes target but warns on rivals</a></h4><ul>   <li>Roku (<a href=\"http://seekingalpha.com/symbol/ROKU\" target=\"_blank\">ROKU</a> <font color=\"red\">-3.3%</font>) has earned a price target hike at Morgan Stanley, based on what it's accomplished to date taking charge of the over-the-top distribution market, but there are heavy headwinds.</li>    <li>The firm raised its target to $50 from $45; that boosted target is still below current price of $55.99, implying 11% downside. It has an Equal Weight rating.</li>    <li>The company's poised to benefit from the Internet-TV shift due to a leading position across consumer hardware and software, Benjamin Swinburne says, but that presents both opportunities and threats: \"Roku is not alone in this market, with a steady drumbeat of larger, better capitalized competitors, leaving shares still priced too rich.\" Competition is \"real and intensifying\" from Amazon.com, Google, Apple and Comcast. (h/t Bloomberg)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3405238\" data-linked=\"Roku dips as Morgan Stanley hikes target but warns on rivals\" data-tweet=\"$ROKU - Roku dips as Morgan Stanley hikes target but warns on rivals https://seekingalpha.com/news/3405238-roku-dips-morgan-stanley-hikes-target-warns-on-rivals?source=tweet\" data-url=\"https://seekingalpha.com/news/3405238-roku-dips-morgan-stanley-hikes-target-warns-on-rivals\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:08 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>19&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3405236\" data-ts=\"1541437582\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SEED\" target=\"_blank\">SEED</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3405236-origin-agritech-leads-consumer-gainers-tuniu-and-funko-among-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Origin Agritech leads consumer gainers; Tuniu and Funko among losers</a></h4><ul>\n<li>\n<b>Gainers: </b>Origin Agritech (NASDAQ:<a href='https://seekingalpha.com/symbol/SEED' title='Origin Agritech Limited'>SEED</a>) <font color=\"green\">+12%</font>. Travelport Worldwide (NYSE:<a href='https://seekingalpha.com/symbol/TVPT' title='Travelport'>TVPT</a>) <font color=\"green\">+9%</font>. Eastside Distilling (NASDAQ:<a href='https://seekingalpha.com/symbol/EAST' title='Eastside Distilling, Inc.'>EAST</a>) <font color=\"green\">+9%</font>. Orchids Paper Products (NYSEMKT:<a href='https://seekingalpha.com/symbol/TIS' title='Orchids Paper Products Company'>TIS</a>) <font color=\"green\">+9%</font>. Pyxus International (NYSE:<a href='https://seekingalpha.com/symbol/PYX' title='Pyxus International, Inc.'>PYX</a>) <font color=\"green\">+8%</font>.</li>\n<li>\n<b>Losers: </b>Pingtan Marine Enterprise (NASDAQ:<a href='https://seekingalpha.com/symbol/PME' title='Pingtan Marine Enterprise Ltd.'>PME</a>) <font color=\"red\">-8%</font>. Funko (NASDAQ:<a href='https://seekingalpha.com/symbol/FNKO' title='Funko, Inc.'>FNKO</a>) <font color=\"red\">-7%</font>. Sonos (NASDAQ:<a href='https://seekingalpha.com/symbol/SONO' title='Sonos, Inc.'>SONO</a>) <font color=\"red\">-7%</font>. Youngevity International (NASDAQ:<a href='https://seekingalpha.com/symbol/YGYI' title='Youngevity International, Inc.'>YGYI</a>) <font color=\"red\">-7%</font>. Tuniu (NASDAQ:<a href='https://seekingalpha.com/symbol/TOUR' title='Tuniu Corporation'>TOUR</a>) <font color=\"red\">-6%</font>.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3405236\" data-linked=\"Origin Agritech leads consumer gainers; Tuniu and Funko among losers\" data-tweet=\"$SEED $SEED $TVPT - Origin Agritech leads consumer gainers; Tuniu and Funko among losers https://seekingalpha.com/news/3405236-origin-agritech-leads-consumer-gainers-tuniu-and-funko-among-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3405236-origin-agritech-leads-consumer-gainers-tuniu-and-funko-among-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:06 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3405233\" data-ts=\"1541437279\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OXNXF\" target=\"_blank\">OXNXF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3405233-onxeo-up-13-on-encouraging-early-stage-data-on-cancer-candidate-asidna\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Onxeo up 13% on encouraging early-stage data on cancer candidate AsiDNA</a></h4><ul> <li>Thinly traded small cap Onxeo S.A. (<a href='https://seekingalpha.com/symbol/OXNXF' title='Onxeo SA'>OTC:OXNXF</a>) is up <font color=\"green\">13% </font>on a 15x surge in volume, albeit on turnover of only 282K shares, in response to its <a href=\"https://seekingalpha.com/pr/17321775-onxeo-announces-positive-interim-results-phase-1-study-asidnatm-first-class-dna-damage\" target=\"_blank\">announcement </a>of positive data from a Phase 1 clinical trial, <a href=\"https://clinicaltrials.gov/ct2/show/NCT03579628?term=onxeo&amp;rank=10\" target=\"_blank\">DRIIV-1</a>, evaluating the safety, tolerability, pharmacokinetics, pharmacodynamics and preliminary efficacy of AsiDNA, a DNA damage response inhibitor, in patients with advanced solid tumors.</li> <li>10 patients received 112 intravenous infusions of AsiDNA ranging from 200 mg to 600 mg. Robust target engagement was observed as early as the second dose level, affirming its mechanism of action. Systematic exposure was observed in a dose-dependent manner.</li> <li>Three patients experienced decreases in tumor proliferation rates as measured by a biomarker while one patient experienced stable cancer.</li> <li>AsiDNA was generally well-tolerated at three dose levels with no serious treatment-related adverse events and no dose-limiting toxicities observed.</li> <li>Phase 1b/2 studies assessing AsiDNA combined with certain chemo agents should launch in 2019.</li> <li>The company says AsiDNA has shown an ability to oppose and even reverse tumor resistance to PARP inhibitors regardless of mutation status.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3405233\" data-linked=\"Onxeo up 13% on encouraging early-stage data on cancer candidate AsiDNA\" data-tweet=\"$OXNXF - Onxeo up 13% on encouraging early-stage data on cancer candidate AsiDNA https://seekingalpha.com/news/3405233-onxeo-up-13-on-encouraging-early-stage-data-on-cancer-candidate-asidna?source=tweet\" data-url=\"https://seekingalpha.com/news/3405233-onxeo-up-13-on-encouraging-early-stage-data-on-cancer-candidate-asidna\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:01 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3405231\" data-ts=\"1541437179\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GOOG\" target=\"_blank\">GOOG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3405231-moodys-britains-digital-tax-be-credit-negative-for-alphabet-fb\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Moody&#39;s: Britain&#39;s digital tax would be &quot;credit negative&quot; for Alphabet, FB</a></h4><ul>\n<li>           Credit rating agency Moody\u2019s<a href=\"https://www.ft.com/content/48849258-e0fa-11e8-8e70-5e22a430c1ad\" target=\"_blank\"> says</a> Britain\u2019s proposed \u201cdigital services tax\u201d would reduce the cash flow of tech giants for years to come and reduce the benefits from the U.S. tax cuts. \n</li>\n<li> If it passes, the levy will be \u201ccredit negative\u201d for those affected, which will include profitable companies making annual global revenues of at least £500M using UK customer data. </li>\n<li> Moody\u2019s says Alphabet (<a href='https://seekingalpha.com/symbol/GOOG' title='Alphabet, Inc. Cl C'>GOOG</a> <font color='red'>-3%</font>)(<a href='https://seekingalpha.com/symbol/GOOGL' title='Alphabet, Inc. Cl A'>GOOGL</a> <font color='red'>-3.1%</font>) and Facebook (<a href='https://seekingalpha.com/symbol/FB' title='Facebook'>FB</a> <font color='red'>-1.6%</font>) seem to be the primary targets of the tax.  </li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3404969-trump-weighs-antitrust-case-big-tech\" target=\"_blank\">Trump weighs antitrust case on Big Tech</a> (Nov. 5)</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3402194-britain-will-target-tech-giants-digital-tax-2020\" target=\"_blank\">Britain will target tech giants with digital tax in 2020</a> (Oct. 29)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3405231\" data-linked=\"Moody&#39;s: Britain&#39;s digital tax would be &quot;credit negative&quot; for Alphabet, FB\" data-tweet=\"$GOOG $GOOG $GOOGL - Moody&#39;s: Britain&#39;s digital tax would be &quot;credit negative&quot; for Alphabet, FB https://seekingalpha.com/news/3405231-moodys-britains-digital-tax-be-credit-negative-for-alphabet-fb?source=tweet\" data-url=\"https://seekingalpha.com/news/3405231-moodys-britains-digital-tax-be-credit-negative-for-alphabet-fb\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:59 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3405229\" data-ts=\"1541436898\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ZTCOY\" target=\"_blank\">ZTCOY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3405229-former-house-intel-chief-urges-review-of-huawei-zte-role-in-sprint\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Former House Intel chief urges review of Huawei, ZTE role in Sprint</a></h4><ul>   <li>Former House Intelligence Chairrman Mike Rogers -- speaking on a call set by the group Protect America's Wireless -- has called for close scrutiny of how Huawei and ZTE (<a href=\"http://seekingalpha.com/symbol/ZTCOY\" target=\"_blank\">ZTCOY</a> <font color=\"red\">-0.9%</font>) would relate to a combination of Sprint (<a href=\"http://seekingalpha.com/symbol/S\" target=\"_blank\">S</a> <font color=\"green\">+1%</font>) and T-Mobile (<a href=\"http://seekingalpha.com/symbol/TMUS\" target=\"_blank\">TMUS</a> <font color=\"green\">+1.3%</font>), Bloomberg reports.</li>    <li>The carrier merger (ultimately reached between parent companies Deutsche Telekom (<a href=\"http://seekingalpha.com/symbol/DTEGY\" target=\"_blank\">DTEGY</a> <font color=\"green\">+0.2%</font>) and SoftBank (<a href=\"http://seekingalpha.com/symbol/SFTBY\" target=\"_blank\">SFTBY</a> <font color=\"green\">+5.7%</font>)) needs approval from the Committe on Foreign Investment in the U.S. to go through.</li>    <li>And the U.S. has considered Huawei a national security threat, and Huawei has close ties to Sprint owner SoftBank.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3405229\" data-linked=\"Former House Intel chief urges review of Huawei, ZTE role in Sprint\" data-tweet=\"$ZTCOY $ZTCOY $S - Former House Intel chief urges review of Huawei, ZTE role in Sprint https://seekingalpha.com/news/3405229-former-house-intel-chief-urges-review-of-huawei-zte-role-in-sprint?source=tweet\" data-url=\"https://seekingalpha.com/news/3405229-former-house-intel-chief-urges-review-of-huawei-zte-role-in-sprint\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:54 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>26&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3405227\" data-ts=\"1541436687\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CRUS\" target=\"_blank\">CRUS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3405227-apple-suppliers-drop-on-production-expansion-halt\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Apple suppliers drop on production expansion halt</a></h4><ul>\n<li>        Apple suppliers are dropping after this morning\u2019s report about halted plans for iPhone XR production expansion.</li>\n<li>               The news follows last week\u2019s earnings miss with a soft holiday guidance and news that Apple will no longer report unit sales numbers. </li>\n<li>               On the move: Cirrus Logic (<a href='https://seekingalpha.com/symbol/CRUS' title='Cirrus Logic, Inc.'>CRUS</a> <font color='red'>-5.4%</font>), Finisar (<a href='https://seekingalpha.com/symbol/FNSR' title='Finisar Corporation'>FNSR</a> <font color='red'>-0.2%</font>), II-VI (<a href='https://seekingalpha.com/symbol/IIVI' title='II-VI Incorporated'>IIVI</a> <font color='red'>-3.8%</font>), Lumentum (<a href='https://seekingalpha.com/symbol/LITE' title='Lumentum Holdings Inc.'>LITE</a> <font color='red'>-0.7%</font>), Qorvo (<a href='https://seekingalpha.com/symbol/QRVO' title='Qorvo, Inc'>QRVO</a> <font color='red'>-7.5%</font>), Skyworks Solutions (<a href='https://seekingalpha.com/symbol/SWKS' title='Skyworks Solutions, Inc.'>SWKS</a> <font color='red'>-4.3%</font>), STMicroelectronics (<a href='https://seekingalpha.com/symbol/STM' title='STMicroelectronics NV'>STM</a> <font color='red'>-4.6%</font>), Universal Display (<a href='https://seekingalpha.com/symbol/OLED' title='Universal Display Corporation'>OLED</a> <font color='red'>-4%</font>).   </li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3404972-stmicroelectronics-announces-launch-share-buy-back-program\" target=\"_blank\">STMicroelectronics announces launch of share buy-back program</a> (Nov. 5)</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3404984-report-apple-cancels-iphone-xr-output-boost\" target=\"_blank\">Report: Apple cancels iPhone XR output boost</a> (Nov. 5)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3405227\" data-linked=\"Apple suppliers drop on production expansion halt\" data-tweet=\"$CRUS $CRUS $FNSR - Apple suppliers drop on production expansion halt https://seekingalpha.com/news/3405227-apple-suppliers-drop-on-production-expansion-halt?source=tweet\" data-url=\"https://seekingalpha.com/news/3405227-apple-suppliers-drop-on-production-expansion-halt\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:51 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>22&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3405223\" data-ts=\"1541436184\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GPN\" target=\"_blank\">GPN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3405223-global-paymentsminus-3-guggenheim-goes-to-sidelines\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Global Payments -3% as Guggenheim goes to sidelines</a></h4><ul>\n<li>        Guggenheim Securities downgrades Global Payments (NYSE:<a href='https://seekingalpha.com/symbol/GPN' title='Global Payments Inc.'>GPN</a>) from Buy to Neutral. (Source: StreetAccount.) </li>\n<li>                  Last week, Global Payments reported Q3 beats and increased its FY18 guidance.    </li>\n<li>               Global Payments shares are currently <font color=\"red\">down 3.1%</font>. GPN is <font color=\"green\">up 2.3%</font> in the past week, <font color=\"red\">down 3.3%</font> in the quarter, and <font color=\"green\">up 14.3% </font>YTD.  </li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3402489-global-payments-beats-0_05-revenue-line\" target=\"_blank\">Global Payments beats by $0.05,  revenue in-line</a> (Oct. 30)</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3402763-wolfe-research-positive-global-payments\" target=\"_blank\">Wolfe Research positive on Global Payments</a> (Oct. 30)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3405223\" data-linked=\"Global Payments -3% as Guggenheim goes to sidelines\" data-tweet=\"$GPN - Global Payments -3% as Guggenheim goes to sidelines https://seekingalpha.com/news/3405223-global-paymentsminus-3-guggenheim-goes-to-sidelines?source=tweet\" data-url=\"https://seekingalpha.com/news/3405223-global-paymentsminus-3-guggenheim-goes-to-sidelines\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:43 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3405217\" data-ts=\"1541435949\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AU\" target=\"_blank\">AU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3405217-anglogoldplus-2-after-seeing-full-year-output-top-of-guidance-costs-debt-fall\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AngloGold +2% after seeing full-year output at top of guidance; costs, debt fall</a></h4><ul> <li>AngloGold Ashanti (<a href='https://seekingalpha.com/symbol/AU' title='AngloGold Ashanti Limited'>AU</a> <font color=\"green\">+2.3%</font>) reports <a href=\"https://www.sec.gov/Archives/edgar/data/1067428/000120561318000178/aga_update.pdf\" target=\"_blank\">Q3 production fell 15% Y/Y</a> to 851K oz. from the same period a year ago but all-in sustaining costs fell 11% to $920/oz. and net debt tumbled 15% to $1.75B.</li> <li>The miner expects full-year production to reach the upper end of its guidance range of 3.325M-3.45M oz.</li> <li>AU says it has started the process of selling the Sadiola mine in Mali, a joint venture with Iamgold (<a href='https://seekingalpha.com/symbol/IAG' title='IAMGOLD Corporation'>IAG</a> <font color=\"green\">+0.3%</font>), after failing to reach agreement on the terms of an investment project with the country's government.</li> <li>AU also says production at South Africa's Mponeng gold mine <a href=\"http://www.miningweekly.com/article/anglogold-ashanti-debt-falls-mponeng-stands-out-2018-11-05\" target=\"_blank\">rose 25% Y/Y</a> on higher grade and  improved mining practices, which, with a performance from surface  operations, took South African operations to a  3% higher 120K oz. at a 17% lower all-in sustaining costs of $1,026/oz.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3405217\" data-linked=\"AngloGold +2% after seeing full-year output at top of guidance; costs, debt fall\" data-tweet=\"$AU $AU $IAG - AngloGold +2% after seeing full-year output at top of guidance; costs, debt fall https://seekingalpha.com/news/3405217-anglogoldplus-2-after-seeing-full-year-output-top-of-guidance-costs-debt-fall?source=tweet\" data-url=\"https://seekingalpha.com/news/3405217-anglogoldplus-2-after-seeing-full-year-output-top-of-guidance-costs-debt-fall\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:39 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3405215\" data-ts=\"1541435782\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MSG\" target=\"_blank\">MSG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3405215-msg-higher-silver-lake-raises-stake-to-7_4\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">MSG higher as Silver Lake raises stake to 7.4%</a></h4><ul>   <li>Madison Square Garden (NASDAQ:<a href='https://seekingalpha.com/symbol/MSG' title='The Madison Square Garden Company'>MSG</a>) is <font color=\"green\">up 3.4%</font> after a morning filing shows Silver Lake has <a href=\"https://seekingalpha.com/filing/4223697\" target=\"_blank\">boosted its stake</a> to about 7.4% of the company.</li>    <li>Through a range of affiliates, the investor beneficially owns 1,427,062 shares, according to the filing.</li>    <li>MSG stock jumped in the summertime (it's <font color=\"green\">up 24.3%</font> YTD), but has fallen off over the past quarter, <font color=\"red\">down 16.8%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3405215\" data-linked=\"MSG higher as Silver Lake raises stake to 7.4%\" data-tweet=\"$MSG - MSG higher as Silver Lake raises stake to 7.4% https://seekingalpha.com/news/3405215-msg-higher-silver-lake-raises-stake-to-7_4?source=tweet\" data-url=\"https://seekingalpha.com/news/3405215-msg-higher-silver-lake-raises-stake-to-7_4\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:36 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3405213\" data-ts=\"1541435613\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MFGP\" target=\"_blank\">MFGP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3405213-micro-focus-hires-new-cfo-resumes-buyback-program\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Micro Focus hires new CFO, resumes buyback program</a></h4><ul>\n<li>        Micro Focus (NYSE:<a href='https://seekingalpha.com/symbol/MFGP' title='Micro Focus International plc ADR'>MFGP</a>) <a href=\"https://seekingalpha.com/filing/4223824\" target=\"_blank\">hires</a> Brian McArthur-Muscroft as the new CFO, replacing Chris Kennedy.</li>\n<li>                  Kennedy is leaving for a new role after roughly 10 months in the job.    </li>\n<li>               The company also announces it intends to recommence its buyback program of ordinary shares (including those underlying its ADR). When initiated, the program will cover an additional tranche of shares for a combined total value of up to $400M. </li>\n<li>               Micro Focus shares are <font color=\"green\">up 2.6%</font> to $16.34.  </li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3405213\" data-linked=\"Micro Focus hires new CFO, resumes buyback program\" data-tweet=\"$MFGP - Micro Focus hires new CFO, resumes buyback program https://seekingalpha.com/news/3405213-micro-focus-hires-new-cfo-resumes-buyback-program?source=tweet\" data-url=\"https://seekingalpha.com/news/3405213-micro-focus-hires-new-cfo-resumes-buyback-program\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:33 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3405210\" data-ts=\"1541435345\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OHI\" target=\"_blank\">OHI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3405210-omega-healthcareplus-4_7-after-q3-beats-guidance-reaffirmed\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Omega Healthcare +4.7% after Q3 beats, guidance reaffirmed</a></h4><ul>\n<li>Omega Healthcare Investors (NYSE:<a href='https://seekingalpha.com/symbol/OHI' title='Omega Healthcare Investors, Inc'>OHI</a>) <font color=\"green\">advances 4.8%</font> in midday trading after<a href=\"https://seekingalpha.com/pr/17321867-omega-announces-third-quarter-2018-financial-results\" target=\"_blank\"> Q3 adjusted FFO per share </a>of 77 cents beat the consensus by 2 cents; compares with 79 cents in the year-ago quarter.</li>\n<li>Q3 operating revenue of $221.9M increased from $219.6M a year ago and exceeded consensus by $28.1M.</li>\n<li>Reaffirms 2018 adjusted FFO guidance range of $3.03-$3.06 per share.</li>\n<li>Sees resolving legacy Orianna facilities in next few months with final resolution resulting in previously stated range of $32M-$38M of annual rent or rent equivalents from assets that previously constituted its Orianna portfolio.</li>\n<li>Says CEO Taylor Pickett: \"In the coming 12 months we would envision returning to our historical growth model where acquisitions meaningfully exceed dispositions.\u201d</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3404989-omega-healthcare-investors-beats-0_02-beats-revenue\" target=\"_blank\">Omega Healthcare Investors beats by $0.02, beats on revenue</a> (Nov. 5)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3405210\" data-linked=\"Omega Healthcare +4.7% after Q3 beats, guidance reaffirmed\" data-tweet=\"$OHI - Omega Healthcare +4.7% after Q3 beats, guidance reaffirmed https://seekingalpha.com/news/3405210-omega-healthcareplus-4_7-after-q3-beats-guidance-reaffirmed?source=tweet\" data-url=\"https://seekingalpha.com/news/3405210-omega-healthcareplus-4_7-after-q3-beats-guidance-reaffirmed\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:29 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>23&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3405207\" data-ts=\"1541435018\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ABEO\" target=\"_blank\">ABEO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3405207-abeona-in-licenses-regenxbios-nav-aav9-vector-for-up-to-580m\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Abeona in-licenses REGENXBIO&#39;s NAV AAV9 vector for up to $580M</a></h4><ul> <li>Abeona Therapeutics (<a href='https://seekingalpha.com/symbol/ABEO' title='Abeona Therapeutics Inc.'>ABEO</a> <font color=\"green\">+1.2%</font>) inks an <a href=\"https://seekingalpha.com/pr/17321981-abeona-therapeutics-regenxbio-announce-worldwide-exclusive-licenses-treatment-four-rare\" target=\"_blank\">agreement </a>with REGENXBIO (<a href='https://seekingalpha.com/symbol/RGNX' title='REGENXBIO'>RGNX</a> <font color=\"red\">-5.6%</font>) for exclusive global rights to its NAV AAV9 vector for the treatment of four diseases: Sanfilippo syndrome type A (MPS IIIA), Sanfilippo syndrome type B (MPS IIIB), Infantile Batten Disease, also known as neuronal ceroid lipofuscinosis type 1 (CLN1 Disease), and Juvenile Batten Disease, also known as neuronal ceroid lipofuscinosis type 3 (CLN3 Disease).</li> <li>Under the terms of the deal, RGNX will receive $20M upfront ($10M at signing and $10M within 12 months), up to $100M in annual fees for years two - six ($20M guaranteed), up to $60M in additional milestones and low double-digit royalties on net sales.</li>\n<li>Investors appear disappointed that RGNX did not receive a higher financial commitment in the deal considering only $40M is assured.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3405207\" data-linked=\"Abeona in-licenses REGENXBIO&#39;s NAV AAV9 vector for up to $580M\" data-tweet=\"$ABEO $ABEO $RGNX - Abeona in-licenses REGENXBIO&#39;s NAV AAV9 vector for up to $580M https://seekingalpha.com/news/3405207-abeona-in-licenses-regenxbios-nav-aav9-vector-for-up-to-580m?source=tweet\" data-url=\"https://seekingalpha.com/news/3405207-abeona-in-licenses-regenxbios-nav-aav9-vector-for-up-to-580m\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:23 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3405205\" data-ts=\"1541434696\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ANW\" target=\"_blank\">ANW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3405205-aegean-marineminus-28-after-uncovering-much-300m-in-fraud\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Aegean Marine -28% after uncovering as much as $300M in fraud</a></h4><ul> <li>Aegean Marine Petroleum (<a href='https://seekingalpha.com/symbol/ANW' title='Aegean Marine Petroleum Network Inc.'>OTC:ANW</a> <font color=\"red\">-28.6%</font>) plunges after saying its latest audit finds as much as <a href=\"http://www.seatrade-maritime.com/news/americas/aegean-marine-auditors-detect-300m-lost-to-fraud.html\" target=\"_blank\">$300M of cash and assets may have been misappropriated</a> through fraudulent activities involving over a dozen company employees.</li> <li>ANw says its investigation shows the principal beneficiary of the  misappropriation is Fujairah-based OilTank Engineering &amp; Consulting,  which entered into a contract several years ago with an ANW subsidiary to oversee the  construction of Fujairah oil terminal facility.</li> <li>A <em>Financial Times</em> report <a href=\"https://seekingalpha.com/news/3404171-ft-auditors-probe-potential-200m-fraud-aegean-marine\" target=\"_blank\">last week</a> said ANW is under investigation by international auditors looking into $200M in fraud involving fake transactions.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3405205\" data-linked=\"Aegean Marine -28% after uncovering as much as $300M in fraud\" data-tweet=\"$ANW - Aegean Marine -28% after uncovering as much as $300M in fraud https://seekingalpha.com/news/3405205-aegean-marineminus-28-after-uncovering-much-300m-in-fraud?source=tweet\" data-url=\"https://seekingalpha.com/news/3405205-aegean-marineminus-28-after-uncovering-much-300m-in-fraud\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:18 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3405202\" data-ts=\"1541434609\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WMK\" target=\"_blank\">WMK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3405202-weis-markets-bid-down-after-earnings\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Weis Markets bid down after earnings</a></h4><ul> <li>Weis Markets (<a href='https://seekingalpha.com/symbol/WMK' title='Weis Markets Inc'>WMK</a> <font color='red'>-6.6%</font>) swings lower after reporting Q3 results late on Friday.</li> <li>Sales were up 1.7% during the quarter to $869M. The company's income before income taxes jumped 172% Y/Y to $18.6M on improved efficiencies in acquired stores it acquired in 2016, price optimization improvements and improved store-level inventory management.</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3404926-weis-markets-reports-q3-results\" target=\"_blank\">Weis Markets reports Q3 results</a> (Nov. 2)</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3405202\" data-linked=\"Weis Markets bid down after earnings\" data-tweet=\"$WMK - Weis Markets bid down after earnings https://seekingalpha.com/news/3405202-weis-markets-bid-down-after-earnings?source=tweet\" data-url=\"https://seekingalpha.com/news/3405202-weis-markets-bid-down-after-earnings\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:16 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3405200\" data-ts=\"1541434476\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CYOU\" target=\"_blank\">CYOU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3405200-changyouminus-4_3-earnings-beat-shows-mobile-user-declines\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Changyou -4.3% as earnings beat shows mobile user declines</a></h4><ul>   <li>Game maker Changyou.com (<a href=\"http://seekingalpha.com/symbol/CYOU\" target=\"_blank\">CYOU</a> <font color=\"red\">-4.3%</font>), higher premarket after its Q3 earnings beat, has turned lower along with former parent Sohu.com alongside some declining user numbers on mobile games.</li>    <li>Revenue slipped 29% but rose 5% sequentially and topped expectations. Online game revenue accordingly fell 28% Y/Y but rose 2% sequentially.</li>    <li>Gross profit fell 35%, to $79M.</li>    <li>And the company swung to a non-GAAP profit of $54M from a year-ago loss of $5M.</li>    <li>Average monthly active accounts of PC games were 2.3M (flat); on mobile games, it was 3.7M, down 29% Y/Y.</li>    <li>Total quarterly aggregate active paying accounts were 0.8M (flat) on PC games, and 0.7% (down 50%) on mobile.</li>    <li>Revenue breakout: Online game, $95.97M (down 27.5%); Online advertising, $4.87M (down 19.7%); Cinema advertising, $15.8M (down 34%); Internet value-added services, $1.31M (down 58%).</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3404960-changyou-com-beats-0_59-beats-revenue\" target=\"_blank\">Changyou.com beats by $0.59, beats on revenue</a> (Nov. 05 2018)</li>    <li><a href=\"https://seekingalpha.com/pr/17321788-changyou-reports-third-quarter-2018-unaudited-financial-results\" target=\"_blank\">Press release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3405200\" data-linked=\"Changyou -4.3% as earnings beat shows mobile user declines\" data-tweet=\"$CYOU - Changyou -4.3% as earnings beat shows mobile user declines https://seekingalpha.com/news/3405200-changyouminus-4_3-earnings-beat-shows-mobile-user-declines?source=tweet\" data-url=\"https://seekingalpha.com/news/3405200-changyouminus-4_3-earnings-beat-shows-mobile-user-declines\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:14 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3405188\" data-ts=\"1541434001\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GALT\" target=\"_blank\">GALT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3405188-galectin-up-10-on-upcoming-data-presentation-supporting-utility-of-breath-test-in-nash\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Galectin up 10% on upcoming data presentation supporting utility of breath test in NASH</a></h4><ul> <li>Galectin Therapeutics (<a href='https://seekingalpha.com/symbol/GALT' title='Galectin Therapeutics, Inc.'>GALT</a> <font color=\"green\">+9.9%</font>) is up modestly higher volume. Shares have rallied over <font color=\"green\">44%</font> since touching $3.85 on October 29.</li> <li>This morning, it <a href=\"https://seekingalpha.com/pr/17322073-data-collected-exalenz-bioscience-galectin-therapeutics-phase-2-nash-cx-trial-gr-mdminus-02\" target=\"_blank\">announced </a>that Exalenz Bioscience (<a href='https://seekingalpha.com/symbol/EXNZF' title='EXALENZ BIOSCIENCE ORD'>OTC:EXNZF</a>) will present data at the upcoming Liver Meeting on the utility of GALT's C-Methacetin Breath Test &#40;MBT&#41; in predicting decompensation in compensated NASH cirrhosis. The results will show that MBT is a better predictor that MELD score, a number based on lab tests that indicates the degree of need for a liver transplant (the higher the number, the more urgent the need), while being non-invasive and advantageous in a point-of-care setting.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3405188\" data-linked=\"Galectin up 10% on upcoming data presentation supporting utility of breath test in NASH\" data-tweet=\"$GALT $GALT $EXNZF - Galectin up 10% on upcoming data presentation supporting utility of breath test in NASH https://seekingalpha.com/news/3405188-galectin-up-10-on-upcoming-data-presentation-supporting-utility-of-breath-test-in-nash?source=tweet\" data-url=\"https://seekingalpha.com/news/3405188-galectin-up-10-on-upcoming-data-presentation-supporting-utility-of-breath-test-in-nash\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:06 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3405191\" data-ts=\"1541433735\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CRMD\" target=\"_blank\">CRMD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3405191-conatus-pharmaceuticals-among-healthcare-gainers-clearside-biomedical-leads-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Conatus Pharmaceuticals among healthcare gainers; Clearside Biomedical leads the losers</a></h4><ul>\n<li>\n<b>Gainers: </b>CorMedix (NYSEMKT:<a href='https://seekingalpha.com/symbol/CRMD' title='CorMedix Inc.'>CRMD</a>) <font color=\"green\">+20%</font>. Gemphire Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/GEMP' title='Gemphire Therapeutics'>GEMP</a>) <font color=\"green\">+14%</font>. Conatus Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/CNAT' title='Conatus Pharmaceuticals'>CNAT</a>) <font color=\"green\">+14%</font>. Aytu BioScience (NASDAQ:<a href='https://seekingalpha.com/symbol/AYTU' title='Aytu BioScience, Inc.'>AYTU</a>) <font color=\"green\">+13%</font>. Puma Biotechnology (NYSE:<a href='https://seekingalpha.com/symbol/PBYI' title='Puma Biotechnology, Inc.'>PBYI</a>) <font color=\"green\">+13%</font>.</li>\n<li>\n<b>Losers: </b>Clearside Biomedical (NASDAQ:<a href='https://seekingalpha.com/symbol/CLSD' title='Clearside Biomedical'>CLSD</a>) <font color=\"red\">-59%</font>. CohBar (NASDAQ:<a href='https://seekingalpha.com/symbol/CWBR' title='CohBar Inc.'>CWBR</a>) <font color=\"red\">-31%</font>. Shineco (NASDAQ:<a href='https://seekingalpha.com/symbol/TYHT' title='Shineco, Inc.'>TYHT</a>) <font color=\"red\">-19%</font>. Marker Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/MRKR' title='Marker Therapeutics Inc'>MRKR</a>) <font color=\"red\">-12%</font>. Health Insurance Innovations (NASDAQ:<a href='https://seekingalpha.com/symbol/HIIQ' title='Health Insurance Innovations'>HIIQ</a>) <font color=\"red\">-11%</font>.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3405191\" data-linked=\"Conatus Pharmaceuticals among healthcare gainers; Clearside Biomedical leads the losers\" data-tweet=\"$CRMD $CRMD $GEMP - Conatus Pharmaceuticals among healthcare gainers; Clearside Biomedical leads the losers https://seekingalpha.com/news/3405191-conatus-pharmaceuticals-among-healthcare-gainers-clearside-biomedical-leads-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3405191-conatus-pharmaceuticals-among-healthcare-gainers-clearside-biomedical-leads-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:02 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3405190\" data-ts=\"1541433612\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GSBD\" target=\"_blank\">GSBD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3405190-goldman-sachs-bdcplus-3_4-after-wells-fargo-upgrades\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Goldman Sachs BDC +3.4% after Wells Fargo upgrades</a></h4><ul>\n<li>Goldman Sachs BDC (NYSE:<a href='https://seekingalpha.com/symbol/GSBD' title='Goldman Sachs BDC'>GSBD</a>) <font color=\"green\">+3.4% </font>after Wells Fargo analyst Finian O'Shea upgrades the stock to outperform from market perform, citing \"defensive attributes in senior composition and leverage headroom.\"</li>\n<li>Price target to $21.75 from $20.00.</li>\n<li>He sees \"generous coverage of the 8.4% dividend yield\" leads to \"strong return while waiting\"; estimates double-digit book return going forward.</li>\n<li>Credit outlook likely to improve as management drives more senior exposures.</li>\n<li>Source: Bloomberg First Word.</li>\n<li>\n<a href=\"https://seekingalpha.com/symbol/GSBD/earnings/analyst_ratings\" target=\"_blank\">Analyst ratings</a>: 2 buys; 4 holds; 1 underperform; average price target $21.86.</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3404523-goldman-sachs-bdc-beats-0_03-beats-total-investment-income\" target=\"_blank\">Goldman Sachs BDC beats by $0.03, beats on total investment income</a> (Nov. 1)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3405190\" data-linked=\"Goldman Sachs BDC +3.4% after Wells Fargo upgrades\" data-tweet=\"$GSBD - Goldman Sachs BDC +3.4% after Wells Fargo upgrades https://seekingalpha.com/news/3405190-goldman-sachs-bdcplus-3_4-after-wells-fargo-upgrades?source=tweet\" data-url=\"https://seekingalpha.com/news/3405190-goldman-sachs-bdcplus-3_4-after-wells-fargo-upgrades\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:00 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3405189\" data-ts=\"1541433601\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MTCH\" target=\"_blank\">MTCH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3405189-analyst-match-competitor-1_1b-ipo\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Analyst: Match competitor could have $1.1B IPO</a></h4><ul>\n<li>        Match Group (<a href='https://seekingalpha.com/symbol/MTCH' title='Match Group, Inc.'>MTCH</a> <font color='red'>-2.4%</font>) competitor Bumble\u2019s IPO <a href=\"https://www.bloomberg.com/news/articles/2018-11-05/tinder-rival-bumble-might-have-to-compromise-on-valuation-in-ipo\" target=\"_blank\">could value</a> the company as low as $1.1B, below the $1.5B it was seeking earlier this year, according to Synovus Trust senior portfolio manager Dan Morgan.</li>\n<li>                  Bumble is talking to banks including JPMorgan about a potential Nasdaq listing but the company has no public financial records to use for valuation estimates.    </li>\n<li>               Morgan used average price/sales multiples of Spark Networks, Meet Group, and Match then applied the resulting multiple to a 2019E revenue of $283M for the valuation total. </li>\n<li>               Bloomberg Intelligence analyst puts the IPO form $1.1B to $1.5B+, excluding any discounts for IPO investors.        </li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3404908-bumble-drops-400m-match-group-suit\" target=\"_blank\">Bumble drops its $400M Match Group suit</a> (Nov. 2)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3405189\" data-linked=\"Analyst: Match competitor could have $1.1B IPO\" data-tweet=\"$MTCH - Analyst: Match competitor could have $1.1B IPO https://seekingalpha.com/news/3405189-analyst-match-competitor-1_1b-ipo?source=tweet\" data-url=\"https://seekingalpha.com/news/3405189-analyst-match-competitor-1_1b-ipo\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:00 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3405187\" data-ts=\"1541433442\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AXL\" target=\"_blank\">AXL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3405187-american-axle-jumps-after-baml-upgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">American Axle jumps after BAML upgrade</a></h4><ul> <li>Bank of America Merrill Lynch upgrades American Axle &amp; Manufacturing (<a href='https://seekingalpha.com/symbol/AXL' title='American Axle & Manufacturing Holdings, Inc.'>AXL</a> <font color='green'>+6.2%</font>) to Neutral from Underperform following the sharp post-earnings share price decline.</li> <li>The firm thinks the issues with MPG plants have been identified and sees a solid plan in place for the business as a whole.</li> <li>\"We would note that AXL has historically been a very good executor and very transparent with the Street, which provides us confidence that a meaningful turnaround is now underway,\" reads the BAML note.</li> <li>A price target of $13 is set on American Axle.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3405187\" data-linked=\"American Axle jumps after BAML upgrade\" data-tweet=\"$AXL - American Axle jumps after BAML upgrade https://seekingalpha.com/news/3405187-american-axle-jumps-after-baml-upgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3405187-american-axle-jumps-after-baml-upgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:57 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3405186\" data-ts=\"1541432886\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SOHU\" target=\"_blank\">SOHU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3405186-sohu-comminus-5_9-revenues-slide-guidance-disappoints\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sohu.com -5.9% as revenues slide, guidance disappoints</a></h4><ul>   <li>Sohu.com (NASDAQ:<a href='https://seekingalpha.com/symbol/SOHU' title='Sohu.com Limited'>SOHU</a>) has <font color=\"red\">slid 5.9%</font> on Nasdaq after its Q3 revenues dropped by double digits and guidance fell short of even low estimates.</li>    <li>Search ads were a lone bright spot as the rest of the business saw sharp declines.</li>    <li>Revenues fell 10.9% Y/Y and dropped 5% sequentially.</li>    <li>Gross margin dropped to 43%, down from a year-ago 49% and last quarter's 44%.</li>    <li>The company swung to a gain of $5M from a year-ago loss of $90M.</li>    <li>Revenue breakout: Brand advertising, $56.96M (down 24%); Search and search-related advertising, $255.1M (up 13.2%); Online games, $95.97M (down 27.5%).</li>    <li>Liquidity was $1.88B as of quarter's end.</li>    <li>It's guiding to Q4 revenues of $465M-$495M, and EPADS of -$1.15 to -$1.40.</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3404961-sohu-com-reports-q3-results\" target=\"_blank\">Sohu.com reports Q3 results</a> (Nov. 05 2018)</li>    <li><a href=\"https://seekingalpha.com/pr/17321788-changyou-reports-third-quarter-2018-unaudited-financial-results\" target=\"_blank\">Press release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3405186\" data-linked=\"Sohu.com -5.9% as revenues slide, guidance disappoints\" data-tweet=\"$SOHU - Sohu.com -5.9% as revenues slide, guidance disappoints https://seekingalpha.com/news/3405186-sohu-comminus-5_9-revenues-slide-guidance-disappoints?source=tweet\" data-url=\"https://seekingalpha.com/news/3405186-sohu-comminus-5_9-revenues-slide-guidance-disappoints\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:48 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3405185\" data-ts=\"1541432885\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PCG\" target=\"_blank\">PCG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3405185-pg-and-eplus-2-q3-profit-excluding-northern-california-fires-edges-higher\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">PG&amp;E +2% as Q3 profit excluding northern California fires edges higher</a></h4><ul>\n<li>PG&amp;E (<a href='https://seekingalpha.com/symbol/PCG' title='PG&E Corporation'>PCG</a> <font color='green'>+1.8%</font>) is higher despite missing Wall Street estimates for <a href=\"https://seekingalpha.com/news/3405094-pg-amp-e-misses-0_01-misses-revenue\" target=\"_blank\">Q3 earnings</a> and revenues, as it records $18M in charges related to the wildfires in the quarter after taking $2.5B in charges in Q2.</li>\n<li>California's biggest utility says Q3 non-GAAP earnings from operations, which exclude items impacting comparability including legal and other costs related to the northern California wildfires, totaled $582M, or $1.13/share, vs. $578M, or $1.12/share, during the same period last year.</li>\n<li>PG&amp;E says it expects to <a href=\"https://www.reuters.com/article/us-pg-e-us-results/california-utility-pge-to-spend-6-billion-on-wildfire-safety-idUSKCN1NA1SV\" target=\"_blank\">spend ~$6B on wildfire safety</a> through 2023.</li>\n<li>PG&amp;E says it is not providing guidance for 2018  GAAP and non-GAAP earnings from operations due to the  uncertainty related to the northern California wildfires but does provide 2018 IIC guidance of  $1.65B-$1.82B in after-tax for costs related to 14  of the wildfires net of insurance, costs related to  the Butte fire net of insurance, and other related costs.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3405185\" data-linked=\"PG&amp;E +2% as Q3 profit excluding northern California fires edges higher\" data-tweet=\"$PCG - PG&amp;E +2% as Q3 profit excluding northern California fires edges higher https://seekingalpha.com/news/3405185-pg-and-eplus-2-q3-profit-excluding-northern-california-fires-edges-higher?source=tweet\" data-url=\"https://seekingalpha.com/news/3405185-pg-and-eplus-2-q3-profit-excluding-northern-california-fires-edges-higher\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:48 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3405183\" data-ts=\"1541432640\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CYDY\" target=\"_blank\">CYDY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3405183-cytodyn-files-ind-for-pro-140-in-tnbc-shares-up-6\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CytoDyn files IND for PRO 140 in TNBC; shares up 6%</a></h4><ul><li>Thinly traded micro cap CytoDyn (<a href='https://seekingalpha.com/symbol/CYDY' title='CytoDyn Inc.'>OTCQB:CYDY</a> <font color=\"green\">+5.7%</font>) is up on below-average volume following its <a href=\"https://seekingalpha.com/pr/17321879-cytodyn-files-ind-protocol-phase-1b-2-clinical-trial-metastatic-triple-negative-breast-cancer\" target=\"_blank\">announcement </a>that it has submitted an IND to the FDA seeking signoff to launch a Phase 1b/2 clinical trial evaluating PRO 140 (leronlimab) in triple negative breast cancer &#40;TNBC&#41; patients. The agency usually responds in ~30 days.</li></ul><div class=\"tiny-share-widget\" data-id=\"3405183\" data-linked=\"CytoDyn files IND for PRO 140 in TNBC; shares up 6%\" data-tweet=\"$CYDY - CytoDyn files IND for PRO 140 in TNBC; shares up 6% https://seekingalpha.com/news/3405183-cytodyn-files-ind-for-pro-140-in-tnbc-shares-up-6?source=tweet\" data-url=\"https://seekingalpha.com/news/3405183-cytodyn-files-ind-for-pro-140-in-tnbc-shares-up-6\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:44 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3405175\" data-ts=\"1541432496\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RBC\" target=\"_blank\">RBC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3405175-regal-beloitplus-3-post-q3-results-raises-fy18-eps-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Regal Beloit +3% post Q3 results; raises FY18 EPS guidance</a></h4><ul> <li>Regal Beloit (<a href='https://seekingalpha.com/symbol/RBC' title='Regal Beloit Corporation'>RBC</a> <font color=\"green\">+3.7%</font>) reported Q3 net sales growth of 8% Y/Y to $925.4M and organic sales growth rate of 5.2% Y/Y.</li> <li>Sale by segments: Commercial &amp; Industrial Systems $462.3M (+13.3% Y/Y), acquisitions, net of divestitures had a positive impact of 8.5%.; Climate Solutions $225.4M (-0.23% Y/Y); and Power Transmission Solutions $207.7M (+7.7% Y/Y).</li> <li>Q3 Gross margin <font color=\"red\">declined by 25 bps</font> to 26.2%; operating margin <font color=\"red\">declined by 351 bps </font>to 7.5% and Adj. operating margin<font color=\"green\"> improved by 60 bps</font> to 11.6%.</li> <li>Segment Adj. operating margins: Commercial &amp; Industrial Systems 8.1% <font color=\"green\">up by 60 bps</font>; Climate Solutions 16.7% <font color=\"green\">up by 50 bps</font>; and Power Transmission Solutions 13.6%<font color=\"green\"> up by 170 bps</font>.</li> <li>Net cash provided by operating activities was $106M, compared to $86.1M a year ago. FCF was at $87.3M (133.3% of adjusted net income), compared to $70.8M a year ago.</li> <li>FY18 Outlook, raised midpoint: GAAP EPS $5.11-5.21 and Adj. EPS $5.85-5.95.</li> <li>Previously: <a href=\"https://seekingalpha.com/news/3405018-regal-beloit-beats-0_07-misses-revenue\" target=\"_blank\">Regal-Beloit beats by $0.07, misses on revenue</a> (Nov. 5)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3405175\" data-linked=\"Regal Beloit +3% post Q3 results; raises FY18 EPS guidance\" data-tweet=\"$RBC - Regal Beloit +3% post Q3 results; raises FY18 EPS guidance https://seekingalpha.com/news/3405175-regal-beloitplus-3-post-q3-results-raises-fy18-eps-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3405175-regal-beloitplus-3-post-q3-results-raises-fy18-eps-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:41 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3405180\" data-ts=\"1541432306\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PLCE\" target=\"_blank\">PLCE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3405180-childrens-placeminus-13-after-guidance-update\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">The Children&#39;s Place -13% after guidance update</a></h4><ul> <li>The Children's Place (<a href='https://seekingalpha.com/symbol/PLCE' title='The Children&#39;s Place Retail Stores, Inc.'>PLCE</a> <font color='red'>-13.1%</font>) falls sharply after the retailer posts a <a href=\"https://seekingalpha.com/pr/17322245-children-s-place-consolidates-key-management-roles\" target=\"_blank\">guidance update</a> alongside an announced  management change of consolidating the CFO and COO positions.</li> <li>PLCE guidance: \"We delivered positive comp sales every month in Q3 resulting in a positive high single digit comp for the quarter. In light of our strong performance, we are reaffirming our Q3 EPS guidance.  Importantly, our inventory is in great shape as we enter Q4.\"</li> <li>By just reaffirming Q3 EPS, the company is guiding for a range with a midpoint below the consensus estimate ($2.97 to $3.07 vs. $3.04 consensus).</li> </ul><div class=\"tiny-share-widget\" data-id=\"3405180\" data-linked=\"The Children&#39;s Place -13% after guidance update\" data-tweet=\"$PLCE - The Children&#39;s Place -13% after guidance update https://seekingalpha.com/news/3405180-childrens-placeminus-13-after-guidance-update?source=tweet\" data-url=\"https://seekingalpha.com/news/3405180-childrens-placeminus-13-after-guidance-update\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:38 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":75,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}